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ABSTRACT OF DISSERTATION 
EXPLORE THE RELATIONSHIP AMONG LUNG CANCER STIGMA, SOCIAL 
SUPPORT, AND PSYCHOSOCIAL DISTRESS 
There is longstanding causal relationship between cigarette smoking and lung 
cancer. Smoke-free policies and anti-smoking campaigns have been linked to the decline 
in smoking acceptance and contribute to the unintended consequence of stigmatizing 
smokers. Lung cancer is viewed as a self-inflicted disease and patients’ feel judged in a 
manner different from other cancers affecting social interactions between family, friends, 
and healthcare professionals. Lung cancer stigma contributes to depression, anxiety, poor 
self-esteem, guilt, shame, blame, threatens a person’s social identity, and limits social 
support that deeply affects patients and their support persons.  
This dissertation contains a review of the literature related to smoking and stigma, 
an evaluation of the psychometric properties of an investigator-developed instrument, 
“Lung Cancer Stigma Scale” (LuCaSS) and the main findings from a cross-sectional 
observational study of 104 lung cancer patients assessing factors associated with lung 
cancer stigma. The Model of Stigma Induced Identity Threat provides the framework to 
examine stigma and the relationship between social constraints, self-esteem, and smoking 
and to test whether social support mediates the relationship between stigma, and 
depression/anxiety.  
The LuCaSS was a reliable and valid instrument measuring lung cancer stigma 
(alpha = 0.89). The principle components analysis determined three subscales measuring 
internalized stigma: social rejections/judgment, blame/guilt, and shame. Social 
constraints, self-esteem, smoking each significantly contributed to the prediction of 
stigma controlling for SES. Lung cancer patients with greater social constraints and lower 
self-esteem and who were smokers scored higher on stigma. Social support was a 
mediator for the relationship between stigma and depression but not for anxiety. The 
findings are consistent with Stigma Induced Identity Threat Model. A stigmatized 
identity can lead to stress-related health outcomes such as depression. 
A lung cancer diagnosis has numerous negative psychosocial effects on patients. 
Integrating stigma tools (i.e. LuCaSS) in practice settings may assist with determining 
potential stigma related distress among lung cancer patients. Emphasizing the need for 
social support and implementing more advocacy efforts may also help minimize the 
 effects of stigma and depression. Future studies are necessary to further examine the role 
of social support in minimizing stigma and psychosocial distress. 
 
KEYWORDS: Stigma, smoking, lung cancer, social constraints, self-esteem, social 
support. 
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CHAPTER ONE  
Introduction 
The causal relationship between cigarette smoking and lung cancer has been 
known for more than 50 years (USDHEW, 1964; US Department of Health & Human 
Services, 2014). Lung cancer is the leading cause of cancer death in men and women in 
the United States (American Cancer Society, 2012). More people die from lung cancer 
than from breast, colorectal, prostate and pancreatic cancer combined and more women 
die from lung cancer than breast cancer. In excess of 160,000 deaths were attributed to 
lung cancer in 2012, with approximately 90% related to cigarette smoking in men and 
almost 80% in women (American Cancer Society, 2012).   
To address the tobacco related disease epidemic, public health initiatives have 
focused on restricting tobacco use through public policy (e.g., smoke-free policies) and 
anti-smoking campaigns for more than 30 years (Fichtenberg & Glantz, 2002). These 
initiatives have been designed to protect non-smokers from the hazards of secondhand 
smoke and de-normalize smoking behavior (Poutvaara & Siemers, 2008). As a result, 
these initiatives have reshaped societal thinking about tobacco use and unintentionally 
placed blame on smokers for the diseases it causes.  
In most areas of the United States, smoking is viewed as an unacceptable behavior 
(Bayer, 2008; Gilpin, Lee, & Pierce, 2004; Alamar & Glantz, 2006; Stuber, et al., 2008). 
The unintended consequences of effective antismoking campaigns and smoke-free 
policies have led to the stigmatization, ostracism, and discrimination of smokers 
(Falomir-Pichastor, et al., 2009). Smokers are often stigmatized and set apart from non-
smoking society members leading to stereotyping, judgment and discrimination. Lung 
cancer is viewed as a self-inflicted disease regardless of person’s smoking status, 
perpetuating the belief that those with the disease do not deserve empathy or support 
(Struber, Galea, & Link, 2008; Chapple et al., 2004). The repercussions may be 
membership in a devalued social group increasing a person’s exposure to stressful 
identity threatening situations (Major and O’Brien, 2005). Identity threat endangers the 
aspect of one’s self or self-esteem, producing physical and psychosocial challenges that 
compromise a person’s quality of life and promote social constraints that may lead to 
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depression and anxiety (Else-Quest, et al., 2009; Carlson et al., 2005; Chapple et al., 
2004).  
The Model of Stigma Induced Identity Threat (Major and O’Brien, 2005) 
provides the framework for this dissertation. Key concepts of the model are tested 
including personal characteristics (socioeconomic status, self-esteem, social constraints 
smoking) and the effects of lung cancer stigma on psychosocial distress (i.e., anxiety and 
depression) and the role of social support as a mediator of those relationships. The model 
posits that being stigmatized produces a threat to the aspect of the self that is derived 
from membership in a devalued social group or category (lung cancer patient) and 
assumes that possessing a devalued social identity increases one’s exposure to potentially 
stressful (identity threatening) situations. A threat to one’s identity can result in 
discrimination and lead to a number of psychosocial distress and negative health 
outcomes such as depression/anxiety and limited social support (Chapple, et al., 2004; 
Major and O’Brien, 2005; Cataldo, et al., 2011; Brown-Johnson, et al., 2014;). Stigma-
induced identity threat results when an individual appraises demands as potentially 
harmful to their social identity and the demand exceeds the resources to cope (Major and 
O’Brien, 2005). 
This dissertation consists of five chapters. Chapter 2 is an integrative review of 
the literature related to smoking stigma and how it pertains to lung cancer and mental 
health outcomes. Stigma is an attribute or behavior that conveys a devalued social 
identity separate from an accepted normal one (Goffman, 1963). Public health initiatives 
aimed at protecting non-smokers and de-normalizing smoking behavior have had 
unintended consequences contributing to the stigma that smokers experience (Struber, 
Galea, & Link, 2008; Chapple et al., 2004). Stigma in healthcare is considered a powerful 
force in the lives of individuals from marginalized groups such as those with HIV/AIDS, 
mental health, cancer, and sexually transmitted infections (Phelan, et al., 2002). 
Stigma affects the psychological wellbeing of those who experience it. Having a 
stigmatized social identity contributes to anxiety, depression, guilt, shame, blame, and 
poor quality of life (Chapple, et al., 2004; Cataldo, et al., 2012; Carlson, et al., 2005; 
Brown-Johnson, et al., 2014; Morse, et al., 2008). Stigma functions by signaling disgust 
in those perceived to be “normal” and shame in those who are stigmatized. Experiencing 
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stigma triggers fear of rejection, limits seeking help and social support, (Corner, et al., 
2005) and is associated with poor health outcomes and decreased survival (Struber, 
Galea, & Link, 2008; Chapple et al., 2004; Cataldo, et al., 2011). 
Chapter 3 describes the development and psychometric testing of the investigator-
developed Lung Cancer Stigma Scale (LuCaSS). Items from validated HIV stigma 
measures were modified for the LuCaSS and framed in the context of lung cancer 
(Berger, et al., 2001; Fife & Wright, 2000; and Elmet, 2005; Sowell, et al., 1997). The 
primary aims of Chapter 3 are to describe the internal consistency of the LuCaSS and 
evaluate the construct validity of the instrument through principle components analysis. 
Testing instruments designed to assess a patient’s perceived stigma and its effects may 
enhance knowledge, empathy and understanding to improve comprehensive, 
nonjudgmental care and develop future prevention strategies.  
Chapter 4 describes the results of a cross-sectional observational study of 104 
lung cancer patients to assess factors (i.e., social support, social constraints and self-
esteem) associated with stigma and how these variables are related to anxiety and 
depression. Testing constructs of the Model of Stigma-Induced Identity Threat, the study 
has three main objectives: 1) explore the relationships among social constraints, self-
esteem, smoking, and stigma; 2) determine the relationships between stigma and anxiety 
and depression, controlling for smoking and socioeconomic status (SES); and 3) 
determine if social support mediates the relationships between stigma and depression and 
stigma and anxiety. It was hypothesized that there would be a relationship between self-
esteem, social constraints, smoking, and lung cancer stigma. Hypothesis 2 was that social 
support would mediate the relationships between stigma, depression, and anxiety.  
Chapter 5 provides a summary of the findings from the dissertation. In addition, 
implications for practice and suggestions for future research, prevention, and advocacy 
are discussed. Also, the ethical considerations associated with deploying stigma as a 
justified means of social control to discourage unhealthy behaviors are discussed. Smoke-
free policies, anti-smoking campaigns and associated media messages are beneficial to 
curbing smoking prevalence and de-normalizing smoking behavior. However, more 
research is needed to understand how stigma impacts initiation and help seeking 
behaviors as well as how social movements may demand action to reduce stigma (Brown, 
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1995). Social movements led and championed by professional associations and advocacy 
organizations may provide effective population-based social support to minimize stigma 
experienced by lung cancer patients, caregivers, and providers.  
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CHAPTER TWO  
Stigma, Smoking, and Lung Cancer: A Systematic Review of the Literature 
Abstract 
Aims: This systematic literature review explored the: a) concepts of health-related 
stigma; b) effects of stigma on the lack of lung cancer research funding and advocacy; c) 
relationship between smoking stigma and lung cancer; and d) overview of the Model of 
Stigma-Induced Identity Threat and the psychosocial effects of being stigmatized.  
Background: Stigma is an attribute that conveys a devalued “social identity” outside of 
an accepted “normal” one. The unintended consequences of smoke-free policies and anti-
smoking campaigns have contributed to the view that smoking is an unacceptable 
behavior and that lung cancer is a “self-inflicted” disease as a result of smoking.  
Data Source: Literature search included the following key words: stigma, smoking, and 
lung cancer. Lung cancer funding and advocacy were also reviewed with regard to their 
relationship with smoking and lung cancer stigma.  
Review Methods: Inclusion criteria included peer-reviewed research manuscripts and 
systematic reviews of research published between January 1998 and December 2014. 
Nineteen manuscripts met the inclusion criteria for smoking, stigma and/or lung cancer. 
Determining eligibility for manuscript selection was achieved through skimming the 
abstracts and titles. 
Results: Stigma is most likely to exist among people with diseases linked to controllable 
causes (smoking) prompting less empathy and more blame. As a result, lung cancer 
patients are seen as responsible or “deserving” of their disease regardless of their 
smoking status. Prevention and cessation efforts, provided through smoke-free policies, 
are essential for lung cancer prevention and treatment. However, the stigma experienced 
by lung cancer patients negatively impacts psychological adjustments and interpersonal 
communication. The Model of Stigma-Induced Identity Threat explains how lung cancer 
stigma “threatens a person’s identity” and is associated with greater distress, poorer 
psychological adjustment and limited use of support services.  
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Lung cancer stigma as “identity threat” has influenced the lag in appropriate 
research funding and advocacy affecting any advances toward better prevention, 
treatment and survival.  
Conclusion: Stigma is a social process resulting in discrediting or devaluation of a 
person or group and exists as a means of social control and regulating behavior. Smoking 
represents the primary risk factor for lung cancer and is the connection to the growing 
negative public perceptions that unintentionally result in stigma against lung cancer 
patients. As a result, lung cancer patients experience higher levels of cancer-related 
stigma than patients with other cancers.  
Key words: smoking, stigma, and lung cancer. 
 
Introduction 
As one of the most common smoking-related malignancies, lung cancer is the 
leading cause of cancer death in men and women in the United States (American Cancer 
Society, 2012). More people die from lung cancer than from breast, colorectal, prostate 
and pancreatic cancer combined and more women die from lung cancer than breast 
cancer. In excess of 160,000 deaths were attributed to lung cancer in 2012, with 
approximately 90% related to cigarette smoking in men and almost 80% in women 
(American Cancer Society, 2012).  Lung cancer is among the most preventable diseases 
(CDC, 2010). 
The hazards of smoking have been well established for more than 50 years (US 
Department of Health & Human Services, 2014) and are known to contribute to an 
epidemic of smoking-related diseases and millions of deaths worldwide. Although active 
smoking is responsible for the majority of new lung cancer cases and deaths, secondhand 
smoke (SHS) exposure is also a cause of lung cancer. More than 7,300 nonsmokers die 
from lung cancer acquired from exposure to SHS each year (U.S. Department of Health 
and Human Services, 2014). Tobacco use presents just one of the known causes of lung 
cancer. There are other carcinogens present in the workplace and home that may increase 
the risk of developing lung cancer such as radon and asbestos exposure. It is estimated 
more than 20,000 radon-induced lung cancers occur each year in the U.S. (United States 
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Environmental Protection Agency, 2012). Radon, an odorless, colorless gas that comes 
from rocks and soil, can get trapped in buildings and, if undetected, increases the risk of 
developing lung disease and cancer (EPA, 2012). In addition, high levels of radon 
combined with smoking produces a synergistic effect adding to the increased risk of 
developing lung cancer. Examples of other substances that may be found in some 
workplaces and increase lung cancer risk include arsenic, some forms of silica, and 
chromium (USDHHS, 2004).  
Other variables known to increase the chances of developing lung cancer include 
gender differences and molecular alterations between never smokers and smokers, 
indicating other potential causes of the disease (Sun, Schiller, & Gazdar, 2007).  Studies 
have shown that the “Y” chromosome, thought to contribute to tumor containment, is 
deleted in the blood of men who smoke making men more susceptible to lung cancer. 
Smoking and age were associated with a loss of “Y” chromosome in the blood, 
increasing the risk for lung cancer in men (Dumanski, Rasi, Lonn, et al., 2014).  In 
women, estrogen or its metabolites may be a factor that increases lung cancer risk. 
Smoking alters estrogen receptors expressed on lung cancer cells, increasing cell 
proliferation of mutated cells and estrogen’s role in both premalignant and malignant 
disease progression (Sun et al. 2007; Couraud, et al. 2012; Taioli &Wynder, 1994; 
Pesatori, Carungno, et al. 2013). EGFR (epidermal growth factor receptor) and EML4-
ALK (echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase) 
are specific mutations found mostly in non-smokers with lung cancer (Rudin, et al. 2009; 
Wing-SzeWong, D., et al. 2009). 
Lung cancer has one of the lowest survival outcomes of any cancer (Howlander, 
et al., 2014). The overall five-year survival rate for lung cancer has not changed in more 
than 40 years (13% in 1970 vs. 17.4% in 2014). The five-year survival rate for lung 
cancer when confined to a primary site, diagnosed and treated, is approximately 53% but 
declines significantly to 3.9% when the cancer has metastasized. Unfortunately, only 
approximately 16% of lung cancer cases are diagnosed in an early-localized stage 
(Howlander, et al., 2014). One factor that contributes to the dismal survival rates is late 
diagnosis of the disease when the tumor is inoperable or has metastasized. Early 
diagnosis greatly improves the chances of long-term survival (ACS, 2012).  
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The purpose of this systematic review was to explore the: a) concepts of health-
related stigma; b) effects of stigma on the lack of lung cancer research funding and 
advocacy; c) relationship between smoking stigma and lung cancer; and d) constructs of 
the Model of Stigma-Induced Identity Threat and the psychosocial effects of being 
stigmatized. 
Methods 
A systematic literature search was conducted via numerous library databases 
(PsycINFO, WebSPIRS, OVIDSP, PubMed, CINAHL) using the key words of stigma, 
smoking, and lung cancer (neoplasms). Lung cancer funding and advocacy were also 
reviewed with regard to their relationship to stigma. Inclusion criteria included 
conceptual definitions of stigma associated with lung cancer and smoking. To be 
included, research studies and systematic reviews were published in peer-reviewed 
journals between January 1998 and December 2014 and limited to the English language. 
Studies that were not specific to health-related stigma were excluded from the search, as 
were those pertaining to treatment, diagnostic, or prevention studies. 
The initial search method produced 111 publications and abstracts. Forty-seven 
studies were regarded as “supportive literature” related to the concept of stigma. Nineteen 
publications met the inclusion criteria for smoking, stigma and/or lung cancer (see Table 
2.1). Determining eligibility of studies was achieved through skimming the abstracts and 
titles.  
Concepts of Health-related Stigma  
Stigma is defined as an attribute, behavior, or reputation that is socially 
discrediting in a specific way that may cause an individual to be mentally classified by 
others in an undesirable, rejected stereotype, rather than in an accepted, normal one 
(Goffman, 1963). Since the original stigma work (Goffman, 1963), the definition of 
stigma has varied considerably to include a characteristic of an individual contrary to the 
norm of the social unit. The meaning of “norm” includes a common belief that a person 
ought to behave in a certain way at a certain time (Stafford & Scott, 1986).  
More recently, the words “stigma” and “stigmatization” refer to an “invisible 
sign” of disapproval permitting “insiders” to draw a line around the “outsiders” in order 
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to distinguish group inclusion limits. The distinction permits “insiders to know who is 
‘in’ and who is ‘out’ and allows the group to maintain its commonality by demonstrating 
what happens to those who deviate from the accepted norm of conduct (Falk, 2001). 
Stigma and the act of stigmatization are an issue of disempowerment and social injustice 
(Scheyett, 2005).  
Link and Phelan (2001) described stigma as “when elements of labeling, 
stereotyping, separation, status loss, and discrimination occur together in a power 
situation that allows them” (p.377). Stigma exists when the following interrelated 
components converge. The first component is that people distinguish and label human 
differences. Second, dominate cultural beliefs associate labeled persons to undesirable 
characteristics and negative stereotypes. Third, distinct categories label persons in order 
to achieve separation of “us” from “them.” The fourth component occurs when labeled 
persons experience a loss in status and discrimination leading to unequal outcomes. 
Lastly, stigmatization is solely dependent on access to social, economic, and political 
power permitting the identification of differentness, creation of stereotypes, division, loss 
of status, and discrimination (Link & Phelan, 2001).  
According to these five components of stigma, the nature of labeling a person 
provides the impetus to separate us from them. The person is thought to be the thing that 
they are labeled. For example, because smoking causes lung cancer, these patients may 
be labeled as “smokers” regardless of their actual smoking status. Another example, 
people who have seizures may be labeled as epileptics instead of a person with epilepsy. 
Labeling helps us understand the social processes involved in how society allows one 
group’s views to dominate what becomes a real and important consequence for another 
group.  
Stigma is further described by sociologist Gerhard Falk (2001) and is categorized 
into two types: 1) existential stigma, and 2) achieved stigma. Existential stigma is derived 
from a condition that occurs without a known cause or from which there was little 
control. Achieved stigma is earned based on a person’s conduct and/or because they 
contributed heavily to the condition or behavior (Falk, 2001). Existential stigma often 
accompanies a cancer diagnosis, because there is a lack of understanding of the cause and 
it is often viewed as a death sentence (Lapore & Revenson, 2007; Chapple et. al., 2004). 
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Patients often experience vulnerability, lack of control over their health, and a need to 
protect others from embarrassment (Rosman, 2004; Frank, 1991). Although the patient 
often asks, “what did I do to cause this?” the reality is that some malignancies are genetic 
occurrences or the cause is unknown and not controllable. Cigarette smoking is a known 
cause of lung cancer, as noted in the 1964 United States Surgeon General’s Report on 
Smoking and Lung Cancer –a clear indication of the causal relationship between cigarette 
smoking and lung cancer (U.S. Department of Health, Education, and Welfare, 1964). A 
lung cancer diagnosis can result in achieved stigma because the disease is considered to 
be “self-inflicted” (Chappel et.al. 2004; Spader, 2008; Gylyn & Youssef, 2010).  
Diseases associated with the highest degree of stigma share common attributes: 
(1) a person with the disease is seen as responsible for having the illness; (2) the disease 
is progressive and incurable; (3) the disease is not well understood among the public; and 
(4) the symptoms cannot be concealed (Goffman, 1963, Falk, 2001). People often try to 
conceal stigmatized health conditions or avoid situations that may reveal these 
conditions, which often lead to delays in seeking health care and information (Link et. al. 
1992, Tod, Craven, Allmark, 2007), unnecessary suffering, lost productivity, and sub-
optimal use of health care resources (Berger, Wagner, & Baker, 2005). Researchers 
conclude that the process of stigmatizing someone is not possible unless they lack social, 
economic or political power in comparison to the person being stigmatized (Link & 
Phelan, 2001). The powerful have greater access to resources and influence. Stigma 
exists when labeling, negatively stereotyping, discriminating against, exclusion, and low 
status co-occur in power situations that allow them to occur (Link & Phelan, 2001).  
Stigma differs from prejudice, stereotype, and discrimination, although they are part of 
the stigma experience. Prejudice is an attitude or negative judgment toward a group and 
its members. Stereotype is a belief about a group, and discrimination is an unjustified 
negative or harmful behavior toward members of a group (Heatherton, et al., 2003).  
In summary, stigma is the expression of negative attitudes about someone or 
something thought to be socially unacceptable. Stigma can be a result of misinformation 
leading to fear and misunderstanding. As the dangers of smoking became more apparent, 
well-intentioned efforts to restrict smoking and exposure to secondhand smoke may have 
caused a negative reaction to smokers. Because smoking represents the primary risk for 
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lung cancer, the disease is still seen by many as self-inflicted. Stigma ascribed to 
controllable factors (achieved stigma) such as smoking elicits a greater negative reaction 
than stigma ascribed to uncontrollable factors (existential stigma) such as breast cancer 
(Weiner, Perry, & Magnusson, 1988). Stigma may also threaten a person’s identity, 
social life, and economic opportunities and deeply affect families and support persons 
(Fife et al. 2000). Stigma associated with disease is dependent on the perception of 
patient responsibility for the disease and whether the disease leads to a serious disability, 
disfigurement, lack of control, or disruption of social interactions (Goffman, 1963; Falk, 
2001; Link, Cullen, Mirotznik, & Struening, 1992; Berger, Wagner, & Baker, 2005). 
Stigma and Lung Cancer Research Funding and Advocacy  
Although lung cancer contributes to one of the highest cancer mortality rates, it 
receives the least amount of federal government research funding compared to breast, 
colon and prostate cancer. Total research spending dollars per death in fiscal year 2010 
was $28,660 for breast cancer; $13,697 for prostate cancer; $6,872 for colon cancer, and 
$1,386 for lung cancer (National Cancer Institute, 2012; Centers for Disease Control & 
Prevention, 2010). The limited research funding for lung cancer may result from the 
public view that lung cancer is a punishment for smoking resulting in stigmatization of 
lung cancer patients (Chapple, et at. 2004; Knapp-Oliver, 2012; Oliver and Moyer 2012). 
The inequity in research funding contributes to the lack of progress and improvement in 
early detection, screening, treatment, advocacy and awareness (Gulyn and Youssef, 
2010). The history of stigma research provides the context for understanding the 
processes related to the disparities noted in lung cancer and the expected outcomes of 
being stigmatized.  
Relationship between Smoking Stigma and Lung Cancer Stigma 
Because of the longstanding causal relationship between cigarette smoking 
(USDHEW, 1964) and lung cancer, smoke-free policies were introduced not only to 
protect non-smokers from exposure to secondhand smoke but also to aid public health 
strategies aimed at de-normalizing smoking and encourage society to view tobacco use as 
undesirable antisocial behavior (Bayer, 2008; Gilpin, Lee, & Pierce, 2004; Americans for 
Non-Smokers’ Rights, 2003; Alamar & Glantz, 2006). Although smoke-free policies 
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have contributed to the decline in tobacco use in the U.S. (Almar & Glantz, 2006), they 
also have added to the stigmatization and prejudice toward smokers (Stuber, Meyer, & 
Link, 2008; Chapple et al., 2004).  
Denormalizing tobacco use by changing the social norms became the basis for the 
tobacco control movement (Bell et al., 2010) including strategies to limit where smoking 
is permitted, how tobacco products are sold, the dangers of first and secondhand smoke 
through media campaigns and exposing the tobacco industry’s manipulative tactics to 
promote their products (Bell et al., 2010).  
The role of social norms, defined as rules or standards that are understood by 
members of a group, are in place to guide and/or constrain social behaviors with or 
without law enforcement. Goffman (1963) argued that stigma is a common feature of any 
society because nonconformity of social norms is unavoidable and persistent. Therefore, 
stigma is a consequence for failing to comply with social norms for the purpose of 
making the nonconformist less deviant so they can rejoin the group (Stuber and Galea, 
2009). For example, when family and friends express disapproval of smoking, these 
social norms contribute to smoker-related stigma (Stuber, et al., 2008). 
The rise of smoke-free policies in the United States not only reminds us of the 
health consequences of secondhand smoke exposure but also that the societal attitude has 
changed and public smoking is no longer considered acceptable (Stuber et al. 2009). The 
unintended consequences of effective antismoking campaigns and smoke-free policies 
have led to stigmatization, ostracism, and discrimination endured by smokers (Falomir-
Pichastor, et al., 2009). In addition, healthcare providers and epidemiologists may 
describe smokers as defiant, weak, making poor choices, or lacking willpower (Street, 
2004). In reality, many smokers attempt to quit numerous times only to relapse due to 
challenges of nicotine addiction and withdrawal (Fiore et.al. 2008). A person who 
smokes may have the desire and willingness to address their smoking addiction and 
comply with the new social norms. However, the addictive nature of nicotine and the lack 
of support for or access to nicotine dependence treatment create a dilemma for the 
smoker.  
Smoke-free policies contribute to stigma in two ways: 1) social policy contributes 
via structural forms of discrimination (private and governmental policies); and 2) 
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symbolic messages or moral condemnation (Schneider & Ingram, 1993). Structural 
policies perpetuate discrimination that restricts opportunities of “marginalized” groups, 
whether intentional or not, and range from companies refusing to hire smokers to 
employers having to pay more for the health insurance of their employees who smoke. 
By way of structural policies, the process to separate or lower placement or status may 
potentiate smoking-related stigma (Pample, 2006; Stuber, and Galea, 2009).  Symbolic 
messages or moral condemnation are designed to punish or segregate a particular group 
from another, thereby increasing stigmatization. Smoke-free laws, designed to protect 
non-smokers, arguably were imposed on the act of smoking and not on the smoker. 
However, these policies that force smokers to huddle outside or segregate them to 
designated smoking rooms at airports, may create the perception of an undesirable 
person. Many smokers view the media as promoters of stigma because television 
advertisement aimed at the young to deter smoking illustrate a dreadful and terrifying 
death, exacerbating fear and anxiety (Chapple et al., 2004). The awareness of smoke-free 
policies by smokers and former smokers contribute to the likelihood of experiencing 
smoker-related stigma (Stuber et al., 2008).  
In summary, as the dangers of tobacco use have become known, well-intentioned 
efforts to restrict it have often led to negative reactions to smokers. Because a history of 
smoking is the primary cause of lung cancer, the disease is seen as self-inflicted, leading 
to a higher incidence of stigma for this type of cancer. Stigma exists among people who 
develop lung cancer, regardless of their smoking status (current, former, or never 
smokers) (Chapple, et. al., 2004; Sun, Schiller, & Gazdar, (2007).   
Model of Stigma-Induced Identity Threat 
Overview. The Model of Stigma-Induced Identity Threat (Major, O’Brien, 2005) 
integrates identity threat models of stigma (Crocker, Major, Steele, 1998) with 
transactional models of stress and coping (Lazarus, Folkman, Smith 1984). An identity 
threat is a threat to the aspect of self that is derived from membership in a devalued social 
group or category (Tajelf and Turner, 1986). The model assumes that possessing a 
consensually devalued social identity (stigma) increases one’s exposure to potentially 
stressful (identity threatening) situations.  The model posits that situational cues, 
collective representations of one’s stigma status, personal beliefs and motives shape 
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people’s appraisals of the significance of those situations for wellbeing (Major, O’Brien, 
2005). Identity threat appraisals result when an individual appraises the demands imposed 
by being stigmatized as potentially harmful to their social identity and those stressors 
exceed the individual’s coping mechanisms. Events are appraised for significance of 
wellbeing and outcomes of this appraisal process directs affective, cognitive, behavioral 
and physiological responses to that event. The response is then involuntary (non-
volitional responses) and/or voluntary (volitional responses) leading to specific outcomes 
(See Figure 1.1).  
Mechanisms of Stigmatization. There are four mechanisms that directly affect 
the psychological wellbeing of those who are socially stigmatized: (1) Negative treatment 
or direct discrimination; (2) expectancy confirmation or self-fulfilling prophecy; (3) 
automatic stereotype activation behavior; and (4) stigma induced identity threat.  
Negative treatment or direct discrimination limits access to certain life domains 
that affect a person’s social status, psychological wellbeing and physical health. For 
example, healthcare systems establish tobacco-free campus policies that clearly designate 
the boundaries where smokers are not permitted to smoke. Those who violate the policy 
face corrective action or reprimands. Also, in accordance with hospital credentialing, 
healthcare providers assess the smoking status of every patient upon admission. Smoke-
free policies and smoking assessment policies signal that the smoking behavior is 
unacceptable and can create a separation between “us” and “them” (Stuber, et al., 2008).  
The accumulation of institutional policies and practices may work to further disadvantage 
those who are stigmatized even when individual prejudice or discrimination are absent.  
Expectancy confirmation or self-fulfilling prophecy occurs when individuals 
perceive negative stereotypes that influence certain behaviors toward a stigmatized 
person in ways that directly affect their thoughts, feelings, and behaviors (Darley and 
Fazio, 1980).  The stigmatized person may then confirm the initial inaccurate 
expectations, stereotypes, or prejudicial attitudes. For example, patients with symptoms 
of lung cancer may delay seeking treatment as a coping mechanism to avoid being judged 
(Corner, et al. 2006). Contributing to this mechanism of stigmatization, when healthcare 
providers perceive lung cancer to be self-inflicted and hopeless, they are less likely to 
offer aggressive treatment options than they would to other cancer patients, especially if 
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the patient continues to smoke (Levealahti, et al. 2007). Important to note is that 
perceptions of situations do not always correspond to objective events. Some individuals 
who are targets of objective discrimination fail to realize it and others believe they are 
victims of discrimination even when they are not (Major et al, 2002b).  
Automatic stereotype activation behavior creates an involuntary reaction in the 
absence of discriminatory behavior on the part of others. These automatic responses are 
referred to as “the power of an idea (over the body)” associated with linkages in memory 
between stereotypes and the behaviors they imply. These memory linkages lead to 
initiation of the stereotype and assimilate the stereotype behavior. Lung cancer patients 
who are aware of the stereotype (blame and guilt) may “automatically” behave differently 
(withdrawn, avoidance) regardless of whether there are observable discriminatory actions 
(Major and O’Brien, 2005). For example, a never smoking female lung cancer patient 
about to receive chemotherapy may tell people who ask when she loses her hair, that she 
has breast cancer because she doesn’t want to be judged.  
Stigma as Identity Threat  
Stigma-induced identity threat is the model that explains how experiencing a 
stigmatized identity can lead to stress and stress-related health outcomes through the 
coping process (Major and O’Brien, 2005). A person’s identity may be derived from their 
race, age, ethnicity, occupation, heritage etc. Social identity provides a sense of 
membership or connection with other people (Tajfel and Turner, 2004), and is a valuable 
key contributor to self-esteem and self-concept. People are motivated to protect their 
identities from anything that may threaten or harm their self-esteem by demeaning or 
devaluing their identity (Steel et al., 2002). Possessing a consensually devalued social 
identity (stigma) increases the potential exposure to stressful or identity threatening 
situations. Stigma-induced identity threat can occur as a result of discrimination or other 
identity related threatening situations leading to psychological, physiological, and social 
outcomes such as depression/anxiety, considerable stress, and limited social support 
(Major and O’Brien, 2005; Steele, Spencer, & Aronson, 2002). Stigma related identity 
threat occurs as a result of three processes that shape a persons’ evaluation of being 
stigmatized and the significance of situations: collective stereotypes/representations, 
situational cues, and individual personal characteristics (Major & O’Brien, 2005) .  
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Collective Stereotypes/Representations are based on prior experiences and 
exposure to the dominant culture (i.e., non-smokers, health care providers, anti-tobacco 
messages). Stigmatized members develop shared understandings of the dominant view of 
their stigmatized status in society (Crocker 1999, 1998; Steele, 1997). Collective 
representations include awareness that individuals are devalued in the eyes of others, 
knowledge of the dominant cultural stereotypes of their stigmatized identity, and 
recognition that they are victims of discrimination (Crocker et al. 1998).  
Collective representations influence how the stigmatized perceive and appraise 
stigma-relevant situations. They can affect the behavior of the stigmatized in the absence 
of obvious forms of discriminatory behavior on the part of others, and even when no 
other person is immediately present. For example, anti-smoking media messages don’t 
directly tell a smoker their behavior is unacceptable. However, they create images that 
may induce harm to the person or others (Crocker et al. 1998).  
Situational cues differ in their social identity threat potential or the extent to 
which they signal one is at risk of being devalued, negatively stereotyped, or 
discriminated against because of ones’ social identity (Steele, et al., 2002). For example, 
when a stigmatized lung cancer patient experiences a threatening situation, such as being 
asked if smoking was the cause of their disease, they may immediately feel blame 
regardless of their smoking history or they may feel incorrectly judged because they 
never smoked. There could also have been exposure to situational cues such as certain 
media messages or images that reinforce negative stereotypes of one’s group (Davies et 
al, 2002).  
Personal Characteristics influence how situations are perceived and appraised. 
There are a number of personal characteristics that contribute to the appraisals such as 
socioeconomic factors, self-esteem, experiencing social constraints, and smoking history. 
The personal characteristic appraisals are explained through sensitivity to stigma, group 
identification, and goals and motives.  
Stigma sensitivity involves expecting to be treated on the basis of their group 
membership (i.e., smoker) rather than their personal identity.  Because a person belongs 
to a certain group they become more sensitive to rejection and they often expect to be 
treated differently. For example, smoking is no longer viewed by society as an acceptable 
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behavior. People with lung cancer who continue to smoke may “expect to be treated” 
with less respect or feel disdain based solely on their group membership of being a 
smoker. The disdain experienced by smokers may directly affect their self-esteem, self-
concept and lead to greater social constraints from family and friends. People who score 
higher on a measure of stigma consciousness or sensitivity are more likely to perceive 
themselves as targets of discrimination at both a personal and group level; they also tend 
to lean more toward words that threaten their social identity (Pinel, 1999). 
Group identification refers to individuals who view their stigmatized social 
identity as an essential part of their self-identity. These individuals are more likely to see 
themselves as objects of personal and group discrimination, especially when the prejudice 
cues they experience are ambiguous. For example, smoke-free workplace policies require 
workers who smoke to go outside. Smokers are expected to “huddle” outside in the cold 
and are singled out by their co-workers as less motivated, unfairly using the smoke break 
as a means to avoid work, and lacking will-power or discipline for continuing to smoke 
(Stuber, et al., 2008). 
Goals and motives also shape how individuals perceive and appraise situations. 
There are two motives that are emphasized in the stigma literature: 1) the motive to 
protect or enhance self-esteem; and 2) belief that the system is just and they are fairly 
treated (Crocker, et al. 1998). For example, not every lung cancer patient believes they 
are to blame for their disease and will reject any notion that they had control over the 
cause or any attempt to stigmatize them. This belief has been reported mostly in former 
or never smokers and those with higher self-esteem, social support and social influence 
(Major, et al., 2002b).   
Identity Threat Appraisal is assessment of the demands, the relevance of the 
situation, and resources to cope with those demands. Threat is the perception that a 
person is at risk for a negative or possibly harmful event (Major and O’Brien, 2005). For 
example, being stigmatized may lead to feelings of rejection, judgment, and limited 
resources or social support (Chapple et al., 2004; Cataldo et al., 2010). Stigma-induced 
identity threat results when a person appraises the demands imposed by a ‘stigma-
relevant’ stressor as potentially harmful to the persons’ social identity and the resources 
to cope are surpassed (Major and O’Brien, 2005). 
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The appraisal process can occur through automatic, nonverbal, instantaneous and 
the unconscious. Appraisals can also result from feelings that are processed from shared 
observations of dominant views (situational cues). The coping mechanisms for identity 
threatening situations are through involuntary and voluntary responses (Major and 
O’Brien, 2005).  
Involuntary responses are coping mechanisms to address identity threat and 
include non-verbal anxiety and physiological/emotional and cognitive responses such as 
elevated blood pressure, increased vigilance and working memory load; and behavioral 
responses that may affect academic achievement and health. These responses do no serve 
to regulate or modify stressful experiences (Major and O’Brien, 2005).  Voluntary 
responses also influence our ability to cope by way of conscious “volitional” efforts to 
control emotion, cognition, behavior, physiology and environmental responses to events 
or circumstances viewed as stressful. Seeking and receiving social support is a voluntary 
response and a coping mechanism (Major and O’Brien, 2005).  
Individuals cope with stigma-induced identity threat in several ways: engaging or 
blaming the discrimination they feel on others versus blaming themselves; disengaging or 
withdrawing their efforts from the situations where they are negatively stereotyped or 
fear being the target of discrimination. Stigmatized groups may also cope with identity 
threat by aligning more closely with their group (Allport, 1954). The advantage of 
belonging to a group is that they can provide those who are stigmatized with emotional, 
informational and influential support, and social validation for their perceptions and a 
sense of belonging. Branscombe et al. (1999) found a positive correlation between group 
identification and self-esteem, resulting in favorable outcomes.  
Outcomes of stigmatization involve coping strategies and trade-offs. Strategies 
necessary to achieve specific outcomes (e.g., preserving self-esteem, limiting anxiety and 
depression) may interfere with achieving other outcomes, such as minimizing prejudice 
and discrimination. (Major & O’Brien, 2005). In order to improve the predicament of the 
stigmatized, we need to seek a better understanding of the factors that contribute to an 
individual’s vulnerability as well as their resilience to stigma so that effective coping 
strategies are identified for dealing with identity-threatening situations.  
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In summary, the Model of Stigma-Induced Identity Threat examines how 
mechanisms of stigma can directly affect the psychological wellbeing of those who are 
socially stigmatized. Identity threat poses a risk to a person’s self that is derived from 
membership in a devalued social group. This can increase a person’s exposure to 
potentially stressful or identity threatening situations. Experiencing a stigmatized identity 
can lead to stress-related health outcomes such as depression/anxiety.  Individuals who 
experience stigma may appraise threatening situations through collective representations, 
situational cues, and personal characteristics. Coping mechanisms for identity-threatening 
situations may occur through involuntary or voluntary responses and the outcomes may 
vary based on one’s coping abilities, their vulnerability and resilience to being 
stigmatized.   
Lung Cancer Stigma and the Effects on Psychological Well-being 
Stigma contributes to depression, anxiety, guilt, shame, and blame (Chapple et al., 
2004; Cataldo et al., 2012; Brown-Johnson, et al. 2014; Morse, et al. 2008). In a 
prospective study, researchers evaluated guilt, shame, and depression among non-small 
cell lung cancer (NSCLC) patients compared to patients’ with breast and prostate cancer. 
Women with NSCLC were found to have increased levels of guilt, shame, and depression 
compared to breast cancer patients. They were also more likely to experience depression 
than their male counterparts. Guilt, shame, and depression may hamper patients’ ability 
to advocate for themselves and may affect treatment outcomes. (Schmidt, Else-Quest, 
Hammes, Eickhoff, Hyde, & Schiller, 2006). In addition, psychological stress responses 
can lead to impaired social responses and interactions between the stigmatized and their 
health care providers (Stuber, et al., 2008). Further, depression, anxiety, (Gonzales and 
Jacobsen, 2010) and feelings of blame can negatively affect the physician-patient 
relationship (Chapple et al., 2004; Street, 2004). Prejudice and discrimination contribute 
to health disparities jeopardizing prevention and treatment efforts (USDHHS, 2002). To 
avoid judgment, lung cancer patients may avoid discussions that draw attention to their 
unhealthy behaviors. Stigma can produce individuals who are feared, avoided, regarded 
as deviant, and even blamed for their choices that caused their affliction (Guttman & 
Salmon, 2004). Lung cancer patients often feel judged in a manner that is different from 
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any other cancer with a less apparent cause, affecting social interactions among family, 
friends, and medical professionals (Chapple, et al. 2004, Sun, Schiller, & Gazdar, 2007).  
Stigma associated with lung cancer also contributes to concealment of illness after 
diagnosis and threatens necessary coping mechanisms that lead to decreased adherence to 
treatment, greater disability and reduced quality of life (Carter-Harris, Herman, et al. 
2014; Conlon et al. 2010). For example, researchers found that healthcare system 
mistrust, stigma and smoking status influenced delay in seeking medical treatment. 
Delaying and concealing illness was related to the expected blame they would receive for 
their illness regardless of their smoking status. Without psychosocial supports, lung 
cancer patients feel shunned by society, their families, and abandoned by the oncology 
community (Corner et al. 2005; Sun, Schiller, & Gazdar, 2007).  
Stigma has been shown to threaten a person’s identity, social life, and economic 
opportunities and deeply effect families and support persons (Fife, et al. 2000). Lung 
cancer stigma and prejudice have been linked to serious health consequences including 
constricting social networks and compromised quality of life (Chapple, et al. 2004; Zoe 
& Raleigh, 2010).  
A cancer survivor’s ability to cope with their diagnosis involves the “mutual 
influence” of their social network (significant others, family, friends) as a means of 
cognitively and behaviorally addressing the stressors of the disease (Lepore & Revenson, 
2007). Individuals who experience stigma may feel constrained and avoid discussing 
their cancer in an attempt to buffer against intrusive thoughts that are upsetting in order to 
limit the amount of negative social interactions. Avoidance may hinder the necessary 
coping processes by limiting contemplation of the experience. The negative effect of a 
person’s intrusive thoughts on mental health is also exaggerated by social constraints. In 
contrast to social constraints, social support can strengthen mental health through 
environments essential for cognitive processing of the traumatic events and by utilizing 
verbal disclosure of thoughts and feelings (Lepore and Helgeson, 1998). 
Social constraints can affect how patients communicate with and confide in their 
health care providers, loved ones, and advocacy organizations. Levelalhti et al. (2007) 
conducted a descriptive study exploring the views of patients with inoperable lung 
cancer, who have survived the first year post diagnosis, in regard to how they frame and 
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conceptualize the onset of their illness (Levelalhti, Tishelman, & Ohlen, 2007). Patients 
experienced a wide array of bodily experiences that may not immediately lead to a 
diagnosis. Some reported symptoms related to other disorders such as heart disease or 
systemic complaints thought to be symptoms or indicators of a serious problem (malaise 
& poor condition). Other symptoms were less frequent but triggered an immediate 
reaction such as debilitating cough and vomiting (Levelalhti, Tishelman, & Ohlen, 2007). 
A lack of a strong communal voice between lung cancer patients and advocacy 
organizations was also reported. The lack of patient advocacy for lung cancer patients 
differs drastically from other cancer groups, such as breast cancer patients, who have 
actively influenced public and professional awareness (Else-Quest et al., 2009; Zoe and 
Raleigh, 2010; Siminoff, et al., 2010). Media coverage for lung cancer is focused on the 
connection with smoking, which study participants emphasized as connections to their 
past rather than their current situation. Media coverage associating stigma and blame 
portrayed the smoker as lax in responsibility to practice self-care and quit smoking 
(Levelalhti, Tishelman, & Ohlen, 2007; Street, 2004). 
Summary 
Researchers have studied the effects of stigma on mental health and relationship 
lifestyles (HIV/AIDS, smoking) for more than 20 years and conclude that the prejudice 
against members of stigmatized or oppressed groups causes undue emotional, social, and 
physical stressors (Bayer, 2008; Bell, et. al., 2010; Struber, Meyer, Link, 2008). 
Researchers have also identified the importance of understanding the linkages between 
stigma, prejudice, discrimination and health, essential in the development of effective 
public health initiatives (Struber, Meyer, Link, 2008). The public attitude and perceptions 
toward lung cancer patients show a lack of concern, caring and sensitivity needed by not 
only health care professionals, but also community members, especially when 
communicating with patients about their illness that many consider “self-inflicted” 
(Chapple et al., 2004).  
Discussion 
There are a number of indicators that determine the social discovery of a disease. 
According to Brown (1995), the following four indicators need to be present: 1) lung 
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cancer patients and their loved ones need to initiate seeking help; 2) there needs to be a 
social movement demanding action for lung cancer patients’; 3) health care professionals 
dealing with the disease must be champions for lung cancer; and 4) having strong 
advocacy organizations is imperative (Brown, 1995). To date, lung cancer has missed 
these key indicators and only recently has stigma been addressed in the media, among 
healthcare providers, and patient advocacy groups. 
Additional studies are needed to further assess attitudes and perceptions of lung 
cancer patients, their families, community members, media, and policymakers.  
Assessing the level of stigma related to smoking and lung cancer among the general 
public is important to better understand barriers to funding research, advocacy, 
prevention and treatment efforts. There may be benefits in examining smoke-free policy 
and anti-tobacco messaging so that they don’t alienate tobacco users from non-tobacco 
users. The message from “Free to Breathe,” a lung cancer advocacy organization is “if 
you have lungs you can get lung cancer” (Freetobreathe.org). The benefits of assessing 
this population may lead to development and testing of population-based interventions to 
reduce societal stigma and enhance advocacy, awareness, and social support. Perhaps we 
have neglected the true source of suffering? If the aim is to minimize “the stress,” 
psychological harm, and increase the self-esteem of the victim, we may have overlooked 
that the perpetrator (society) is the problem and not the victim. We seem to have chosen 
to focus on the problems of the oppressed rather than on the problem of the oppressor 
(Meyer, 2003).  
Conclusion  
For more than 160,000 Americans, a lung cancer diagnosis can mean a death 
sentence. Assessment of the effects of stigma associated with smoking and lung cancer 
may provide insight into the threat to social support, advocacy efforts and adequate 
research funding. Addressing the stigma felt by so many lung cancer patients may also 
pave the way toward the development of population-based interventions that limit the 
effects of stigma and judgment threatening the psychological wellbeing of lung cancer 
patients and their families. 
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Table 2.1 Stigma, Smoking and Lung Cancer Summary of the Literature 
Author(s) Citation Purpose/Design Sample/Methods Findings/Conclusion 
1. Alamar, B., & Glantz, S. (2006). 
Effect of increased social 
unacceptability of cigarette smoking 
on reduction in cigarette consumption. 
American Journal of Public Health, 
96,1359-1363. 
Cigarette consumption 
affected by taxes and social 
factors. Impact measured with 
social unacceptability index 
regarding permissible 
locations for smoking. 
Data on cigarette prices 
and consumption from tax 
burden on tobacco, survey 
data on individual attitudes 
toward smoking policy. 
Policies that increase the social 
unacceptability of smoking and taxes 
that increase cigarette prices have 
similar effects in terms of reducing 
cigarette consumption. Social 
unacceptability index and price effects 
are independent. 
2. Bayer, R. (2008). Stigma and the 
ethics of public health: not can we but 
should we. Social Science & Medicine, 
67, 463-472. 
Provides a systematic review 
of stigma, the targets, and the 
effects on public health, the 
moral concerns. 
Systematic review of 
stigma and public health 
literature. HIV/AID and 
smoking stigma, ethics 
It is the responsibility of public health 
officials to counteract stigma if they 
are to fulfill their mission to protect 
community health. Mobilization of 
stigma may effectively reduce the 
prevalence of behaviors linked to 
disease and death and human rights 
issues. 
3. Brown-Johnson, C., Brodsky, J., 
Cataldo, J. (2014). Lung cancer 
stigma, anxiety, depression, & quality 
of life. Journal of Psychosocial 
Oncology, 32, 59-73. 
Investigated lung cancer 
stigma, anxiety, depression 
and QOL & validated variable 
similarities between ever and 
never smokers. Descriptive 
cross-sectional study, 
correlational design. 
Evaluating relationships 
among anxiety, 
depression, LCS, & QOL. 
Online questionnaire 
N=149. 
LCS is positively associated with 
anxiety and depression and negatively 
associated with QOL. Regardless of 
smoking status, lung cancer patients 
experience LCS. 
Table 1.1 (Continued) 
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4.  Carter-Harris, L., Hermann, C., 
Schreiber, J., Weaver, M., Rawl, S. 
(2014). Lung cancer stigma predicts 
timing of medical-help-seeking 
behavior. Oncology Nursing Forum, 
41, 3, E203-E208. 
Examines relationships among 
demographic variables, 
healthcare system distrust, 
lung cancer stigma, smoking 
status, & timing of medical 
health-seeking behavior in 
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Figure 1.1 An Identity-Threat Model of Stigma in Lung Cancer  
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CHAPTER THREE  
Lung Cancer Stigma Scale (LuCaSS):  
Measuring Perceived Stigma in People with Lung Cancer 
Abstract 
Purpose/Objectives: Describe the development of an investigator-developed instrument, 
“Lung Cancer Stigma Scale” (LuCaSS) and evaluate its psychometric properties by: 1) 
describing the internal consistency of the LuCaSS; and 2) assessing the construct validity 
of the instrument through principle components analysis (PCA).  
Design: Psychometric analysis of cross-sectional descriptive data set. 
Sample: 104 patients diagnosed with lung cancer.  
Methods: Cronbach’s alpha coefficients to assess internal consistency and Principle 
Components Analysis (PCA) and to assess dimensionality and construct validity of the 
15-item LuCaSS. 
Findings: The LuCaSS was a reliable and valid instrument measuring lung cancer stigma 
(alpha = 0.89). The principle components analysis determined three subscales measuring 
internalized stigma: social rejections/judgment, blame/guilt, and shame.  
Conclusions: Lung cancer patients are at high risk for psychological distress. Feelings of 
rejection/judgment, blame/guilt and shame can manifest as a result of feeling stigmatized. 
Testing instruments that assess stigma assist in understanding the salient constructs 
associated with stigma and research tools needed to further the study of and test 
interventions to minimize stigma experienced by lung cancer patients. 
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Introduction 
Lung cancer is the most common smoking-related malignancy and the leading 
cause of cancer death in both men and women (United States Cancer Statistics, 2015). 
Lung cancer poses many challenges to those afflicted because of high mortality rates, 
(Howlander et al., 2014), psychological stressors (Gonzalez and Jacobsen, 2010; Cataldo 
et al., 2010; Carlson, et al. 2005), and societal stigma (Chapple, et al. 2004; Cataldo et al. 
2011). These challenges can weaken a person’s essential beliefs and expectations about 
themselves and their illness, their relationships, and their future (Lepore & Revenson, 
2007).  
The public often holds misperceptions about lung cancer and smoking. Some 
believe lung cancer is justified as they think only smokers get lung cancer; the disease is 
self-inflicted; and they deserve it. As a result, lung cancer patients may suffer from 
societal stigma and its consequences (Couranud, et al., 2012; LoConte, et al., 2008; 
Chappel, et al., 2004). 
Stigma is considered a powerful force in the lives of individuals believed to be 
marginalized such as HIV/AIDS, mental health, cancer, and sexually transmitted 
infections (Link and Phelan, 2001). Testing instruments designed to assess a patient’s 
perceived stigma and the effects on their psychological well being may be advantageous 
to enhancing our knowledge, empathy and understanding so we can improve our ability 
to provide comprehensive, nonjudgmental care. It may also provide opportunities for 
health care providers to advocate for these stigmatized populations, promote earlier 
diagnosis, and minimize the adverse effects of feeling stigmatized.   
The purpose of this study was to describe the development of an investigator-
developed instrument, “Lung Cancer Stigma Scale” (LuCaSS) and evaluate its 
psychometric properties by: 1) describing the internal consistency of the LuCaSS; and 2) 
assessing the construct validity of the instrument through principle components analysis 
(PCA).  
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Background 
Smoking, Lung Cancer and Stigma 
There has been a longstanding causal relationship between cigarette smoking and 
lung cancer (USDHEW, 1964). In recent years, there has been an increase in the social 
unacceptability of smoking in the United States linked to smoke-free policies and 
changes in social norms (Bayer, 2008; Gilpin, Lee, & Pierce, 2004; Alamar & Glantz, 
2006; Stuber 2008; Fichtenberg & Glantz, 2002). These policies were introduced not only 
to protect non-smokers from exposure to secondhand smoke but also to aid public health 
strategies designed to de-normalize smoking and encourage society to view tobacco use 
as an undesirable and antisocial behavior (Bayer, 2008; Gilpin, Lee, & Pierce, 2004; 
Americans for Non-Smokers’ Rights, 2003; Alamar & Glantz, 2006). De-normalizing 
tobacco use became the basis for the tobacco control movement (Bell et al., 2010) 
including strategies to limit where smoking is permitted, how tobacco products are sold, 
the dangers of first- and secondhand smoke through media campaigns, and exposing the 
tobacco industry’s manipulative tactics used to promote their products (Bell et al., 2010). 
The meaning of “norm” implies the common belief that a person ought to behave in a 
certain way at a certain time (Stafford & Scott, 1986). 
Although smoke-free policies have contributed to the decline in tobacco use in the 
U.S. (Almar & Glantz, 2006), they also have contributed to the stigmatization and 
prejudice toward smokers (Struber, Galea, & Link, 2008; Chapple et al., 2004).  The 
stigmatization of smokers and the strong relationship between smoking and lung cancer 
may promote the stigma felt by both smokers and those diagnosed with lung cancer 
(Bayer, 2008).  
A lung cancer diagnosis creates additional challenges for patients and families 
due to the societal perception that lung cancer is a smoker’s disease (Chapple, et al., 
2004; LoConte, et al., 2008) and that people who smoke willfully bring the disease on 
themselves (Struber, et al., 2008). This perception can lead to a number of emotions 
including a sense of guilt, shame, anger, blame and remorse (Chapple, et al., 2004; 
Carmack, et al., 2008).  As a result, people with lung cancer may experience greater 
fears, lower self-esteem, emotional distress, and feelings of isolation, anxiety, and 
depression (Gonzalez and Jacobsen, 2010; Cataldo, et al., 2011; Johnson, et al., 2014; 
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Siminoff, et al., 2010). People diagnosed with lung cancer often experience negative 
reactions from others such as criticism from family and societal blame. They often endure 
feelings of guilt, and the emotions may become so stressful that they often delay or 
decide not to seek appropriate screening and treatment (Tod, et al., 2010; Corner, et al., 
2005). 
Stigma Research and Repercussions of Stigma 
Stigma is defined as an attribute, behavior, or reputation that is socially 
discrediting in a specific way that may cause an individual to be mentally classified or 
labeled by others in an undesirable, rejected stereotype, rather than in an accepted, 
normal one (Goffman, 1963). The person who experiences stigma is thought to be the 
thing they are labeled. For example, lung cancer is associated with smoking, so people 
diagnosed with lung cancer are often considered by society as “smokers”, regardless of 
their smoking status.  
Stigmatization is an issue of disempowerment and social injustice (Scheyett, 
2005). Stigma associated with disease may be linked to the perception that the patient is 
responsible for the disease and whether it leads to serious disability, disfigurement, lack 
of control, or disruption of social interactions (Goffman, 1963; Falk, 2001; Link, 
Struening, et.al. 2001; Berger, Wagner, Baker, 2005).  
Lung cancer carries with it greater social stressors and societal stigma than other 
cancers or other chronic diseases (Chapple, 2004; Conlon, 2010, Cataldo, 2011). The 
public perception is that the disease is mostly preventable or associated with controllable 
factors. Controllable factors create strong negative reactions (Weiner, Perry, Magnusson, 
1988) affecting social interactions among all lung cancer patients regardless of their 
smoking status (Raleigh, 2010).  
Perceived stigma contributes to greater depressive symptomatology (Gonzales, 
2010), feelings of shame for having caused the disease or guilt for not having prevented it 
(Chapple, Ziebland, & McPherson, 2004), and feelings of blame that can negatively 
affect psychosocial support between patient and physician and/or patient and family 
(Chapple, et al., 2004). Limited psychosocial supports leave patients feeling ostracized by 
the public, abandoned by the oncology community (Sun, Schiller, Gazdar, 2007), and 
contribute to a lack of empathy for the patient (Morse, Edwardsen, Gordon, 2008). Lung 
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cancer patients often feel judged in a manner that is different than other cancers with a 
less apparent cause. This feeling of being judged can affect social interactions among 
family, friends, and medical professionals (Chapple, et al. 2004, Sun, Schiller, Gazdar, 
2007).  
Stigma associated with lung cancer also contributes to concealment of illness after 
diagnosis and threatens necessary coping mechanisms that may lead to decreased 
adherence to treatment, greater disability and reduced quality of life (Chapple et al., 
2004; Morse, et al. 2008; Lobchuk, et al. 2008). Judgment, feeling ostracized, blame, and 
guilt contribute to lack of treatment by more than half of all people with advanced lung 
cancer, far more than for any other type of cancer (Small, et al., 2012; Earle, et al., 2002; 
Ramsey, et al., 2004).  
Methods 
Development of the Lung Cancer Stigma Scale (LuCaSS) 
When the Lung Cancer Stigma Scale (LuCaSS) was initially developed, there 
were no other measures of lung cancer stigma. Much of the groundwork for measuring 
stigma originated from HIV research: The HIV Stigma Scale (Berger, et. al. 2001; Social 
Impact Scale (Fife & Wright, 2000), and HIV Stigma Scale (Emlet, 2005; Sowell et al., 
1997). These instruments have been consistently used and are considered to be the most 
reliable and valid instruments for measuring HIV related stigma (Bunn, Solomon, Miller, 
Forehand, 2007). Each of the three instruments was chosen because they evaluated a 
diverse population (i.e., elderly, gender-specific, ethnic and cultural differences) and one 
evaluated stigma in HIV patients compared to cancer patients (Fife & Wright, 2000). 
Although the main focus of the survey questions has been to examine perceptions of 
stigma related to HIV/AIDS, they have been adapted to examine the perception of stigma 
in other health conditions (Else-Quest, et al., 2009). Table 3.1 provides a summary of the 
three instruments used to develop the LuCaSS.  Below is a brief summary of each of the 
three existing instruments that were adapted to form items for the LuCaSS. 
Berger’s HIV Stigma Scale. Berger and colleagues (2001) developed an 
instrument to measure perceived stigma experienced by people with HIV based on the 
stigma literature and psychological aspects of having HIV. The Model of Perceived 
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Stigma in people with HIV was developed and the final instrument yielded 40-items on a 
4-point Likert scale (strongly disagree, disagree, agree, and strongly agree). A high score 
indicated stronger agreement with the item. The reading level was below sixth grade 
(Berger, et. al., 2001). Examples include: “I work hard to keep my HIV a secret; I feel 
guilty because I have HIV.” The Cronbach’s alpha for this scale was .96. Five of the 40 
items representing rejection, judgment, and guilt dimensions were adapted for the 
LuCaSS based on feedback from an expert panel (see below). Examples of the items 
adapted from the Berger instrument and the dimension it reflects: “I have been hurt by 
how people reacted to learning I have lung cancer (rejection);” “I feel guilty because I 
have lung cancer (guilt).” 
Social Impact Scale. Fife & Wright (2000) developed the “Social Impact Scale,” 
grounded in the Modified Labeling Theory (Link et al., 1989) to assess the effects of 
stigma associated with HIV/AIDS and cancer on self-esteem. Based on information from 
previous studies and focus groups, the final instrument yielded 24 items measuring four 
dimensions of perceived stigma: social rejection, internalized shame, social isolation, and 
financial insecurity (Fife & Wright, 2001). Examples of instrument items are: “I have 
been treated with less respect than usual by others (judgment)”; I feel others avoid me 
because of my illness (rejection)”; and “I feel others think I am to blame for my illness 
(blame).” The Cronbach’s alphas ranged from .85 to .90 (Fife & Wright, 2000). Seven of 
the 24 items representing rejection, judgment, blame and shame dimensions were adapted 
for the LuCaSS. 
HIV Stigma Scale. The HIV Stigma Scale was originally developed by Sowell et 
al. (1997), measures how often individuals have thoughts and feelings of being 
stigmatized or feel threatened because of their illness. The greatest contribution of this 
scale is that it recognizes that stigma is not a one-dimensional occurrence (Emlet, 2005). 
The 13-item instrument utilizes a 4-point Likert type scale ranging from 1 to 4 (1-not at 
all, 2-rarely, 3-sometimes, and 4-often). Examples of survey items: “I felt ashamed of my 
illness (shame);” “I avoided getting treatment because someone might find out about my 
illness (shame);” and “People who know I am HIV (lung cancer) positive treat me with 
kid gloves (rejection).” Cronbach’s alpha was .83. Three of the 13 items representing 
rejection and shame were adapted for the LuCaSS. 
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Modification of these items was necessary to frame them in the context of lung 
cancer. For example, “I avoided getting treatment because someone might find out about 
my HIV” was modified to, “I avoided getting treatment because someone might find out 
about my lung cancer.”  
Evaluating the Psychometric Properties of the LuCaSS  
Design and Procedure. 
A convenience sample of lung cancer patients (N = 104) were invited to complete 
a cross-sectional 15-item questionnaire, the Lung Cancer Stigma Survey (LuCaSS), and 
they each received a $10 gift card. A total of 125 patients were approached to participate 
between July and August 2014 (participation rate = 83.2%). Of these participants, 
twenty-one (16.8%) declined due to fatigue or poor health. The university’s medical 
institutional review board approved the study materials and procedures. With approval 
from clinic physicians, patients were pre-screened by diagnosis before approached by 
research staff.  There were two methods for administering the survey: 1) REDcap 
(Research Electronic Data Capture) electronic data capture tool; or 2) paper/pencil for 
participants who preferred this method. REDcap is a secure web-based application for 
building and managing online surveys and databases that is hosted by the university and 
facilitated by the researcher. All participants chose the REDcap electronic version as the 
preferred method of participation in this study. Confidentiality was maintained by 
conducting all interviews in the clinic patient rooms where each question was read aloud 
to the patient by the research staff.  
Sample Recruitment. 
The sample was recruited from a medical/surgical thoracic oncology clinic at an 
urban academic tertiary care medical center. The study aims were explained to the 
medical/surgical thoracic oncology physicians during tumor conference prior to 
recruitment. Permission to recruit participants was obtained and patients were pre-
screened to determine study eligibility: confirmed non-small cell lung cancer (NSCLC) 
or small cell lung cancer (SCLC) diagnosis, 18 years and older, and able to read and 
understand English.  
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Instrument. 
An eight-member panel of five lung cancer survivors and three healthcare 
professionals with degrees in sociology and psychology disciplines with stigma expertise 
agreed to serve as reviewers to determine content validity. Based on procedures 
recommended by Streiner and Norman (2008), content experts were asked to assess the 
degree to which each of the 65-items from the three pre-existing instruments related to 
the concept, clarity, and relevance of stigma in people diagnosed with lung cancer. Of the 
65 items reviewed, 45 items were discarded based on a lack of relevance to lung cancer 
patients. Of the twenty remaining items, five were discarded due to redundancy. The final 
lung cancer stigma survey (LuCaSS) included 15 items (see Table 3.1), each scored on a 
4-point Likert scale ranging from “1” (strongly disagree) to “4” (strongly agree). The 
response options were arranged so that higher scores indicated greater perceived stigma.  
Data Analysis. 
To determine summary scores from responses, descriptive statistics (means and 
standard deviations or frequency distributions) were calculated for all variables. Internal 
consistency of the total scale and the subscales was determined by estimating Cronbach’s 
alpha. Pearson’s correlation coefficients were used to estimate the associations among the 
LuCaSS subscales. To assess the size and adequacy of partial correlations among 
variables, the Kaiser-Meyer-Olkin Measures of Sampling Adequacy (MSA) was applied 
to determine whether the associations were sufficient for factorability. MSA scores 
greater than 0.60 are deemed sufficient for factorability (Kaiser, 1981), and the MSA 
score for this study was 0.86 (p< .001).  The sample was found to be favorable for 
factorability adequacy using both the Kaiser-Meyer-Olkin Measures of Sampling 
Adequacy (MSA) (Kaiser, 1981) and the Bartlett Sphericity Test (Dziuban & Shirkey, 
1974).  
Principle components analysis was done to assess the dimensionality and 
construct validity of the 15-item LuCaSS. The number of subscales was indicated by the 
relative size of eigenvalues, as displayed in the corresponding scree plot. A factor-loading 
cutoff of .5 was used to gauge which items loaded on which factors. The varimax rotation 
was specified for maximum subscale separation. All data analysis was done using SPSS 
22.0 (SPSS Inc.) 
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Results 
Sample Characteristics 
The sample comprised 104 patients with lung cancer (all stages and types) 
between the ages of 18 and 85 (see Table 3.2). The average age was 61.9 years (SD =9.2). 
About half of the participants were male (52.0%) and the majority was Caucasian 
(85.6%). Almost sixty percent had graduated from high school and equal percentages 
were retired or unemployed/disabled (41.3%). More than three-fifths of participants were 
former smokers (63.0%) and 21.2% were current smokers. 
Internal Consistency Reliability 
The Cronbach’s alpha for the total 15-item Lung Cancer Stigma Scale (LuCaSS) 
was 0.89. The Cronbach’s alpha calculated for each of the three subscales also provided 
evidence of internal consistency reliability (See Table 3.3). The alphas for the three 
subscales ranged from 0.71 to 0.87. Table 3.4 displays the correlations among the 
LuCaSS subscales and Cronbach’s alphas. There were eight items in the 
judgment/rejection subscale (Cronbach’s alpha = 0.87); three items in the blame/guilt 
subscale (Cronbach’s alpha = 0.74); and four items in the shame subscale, (Cronbach’s 
alpha = 0.71). These subscales indicated a positive correlation with each other and with 
the total score. The strongest correlation was between the total score and the 
judgment/rejection subscale. 
Construct Validity of the Lung Cancer Stigma Scale (LuCaSS) 
Construct validity was evaluated using principle components analysis to 
determine the underlying structure of the LuCaSS (See Table 3.3).  Principle components 
analysis with varimax rotation produced three components with eigenvalues greater than 
1, explaining 40.8%, 8.9%, and 8.7% of the variance, respectively. The three components 
explained a total 58.5% of the variability among items in the LuCaSS. A 4-point Likert-
type scale (strongly disagree, disagree, agree, strongly agree) was used with a score of 
four indicating the strongest sense of stigma; all of the items had the same polarity so no 
reverse coding was necessary.  
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Factor 1. Rejection and judgment subscale 
The first subscale consisted of eight items with loadings ranging from 0.52 to 
0.78.  Seven items had loadings greater than 0.6 on this component. One of these seven 
loaded moderately (0.52) on another subscale (i.e., blame/guilt) but was included here 
due to higher (0.64) loading on this subscale. One other item loaded on this component] 
with a moderate loading of 0.53. These items took the form of rejection and judgment 
related to the patient’s personal sense of stigma (Table 3.4).  
Factor 2. Blame and guilt subscale 
There were three items that loaded on the second component, with loadings 
ranging from 0.62 to .081. This factor captured the constructs of blame and guilt 
identified from the lung cancer stigma literature and consistent with the blame/guilt 
subscale adapted from the HIV/AIDS scale.  
Factor 3. Shame subscale  
Four items loaded on the third component, with loadings ranging from 0.57 to 
0.77; these items captured the construct of shame associated with lung cancer.  
Discussion 
The final 15-item instrument is representative of a persons’ internalized 
experience with feeling stigmatized, with three subscales including social 
rejections/judgments, blame/guilt, and shame. The overall Cronbach’s alpha for the 
LuCaSS was 0.89, reflecting that the instrument has strong internal consistency reliability 
in measuring lung cancer stigma. The principle components analysis determined there 
was three subscales that together measured stigma among lung cancer patients. The three 
subscales that emerged in the analysis are consistent with constructs identified in studies 
of other stigma-associated diseases (Berger et al., 2001; Else-Quest, et al., 2009; Carlson, 
et al. 2005; Cataldo, et al., 2011). The 15-item LuCaSS instrument measures internalized 
stigma including constructs of social rejections/judgment, blame/guilt, and shame.  
Lung cancer patients are at high risk for psychological distress. Feelings of 
rejection/judgment, blame/guilt and shame have been identified in lung cancer and they 
can create psychological distress that can manifest as a result of being stigmatized. In 
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addition, persons who are stigmatized experience depression, anxiety, lack of social 
support and a decrease in quality of life that contribute to low self esteem and social 
constraints (Else-Quest, et al., 2009; Carlson, et al. 2005; Chapple, et al., 2004; Carmack 
et al., 2008; Gonzalez and Jacobsen, 2010; Cataldo, et al., 2011; Johnson, et al., 2014; 
Greene and Banerjee, 2006). Hence, understanding the salient constructs that are 
associated with stigma among lung cancer patients can provide guidance in preventing or 
reducing stigma. For example, noting that a lung cancer patient scores high on feelings of 
judgment or rejection provides an opportunity to acknowledge, empathize and offer 
support to the patient.  
Limitations of this study include convenience sampling reducing generalizability 
to the broader lung cancer population. The small sample size consisted of mostly 
Caucasian participants from one clinical setting and lacked ethnic and cultural diversity. 
Further studies would benefit from a larger, more diverse sample. Given the lack of 
stigma measures for lung cancer, it is important to further develop and test brief measures 
that could be used by both researchers and clinicians to appropriately assess the stigma 
experience. Based on the findings reported here, the LuCaSS is a reliable and valid 
measure of lung cancer stigma and may be useful in identifying individuals who feel 
stigmatized and could benefit from tailored interventions.  
Stigma is an obstacle to prevention, treatment, and access to healthcare among 
patients with HIV/AIDS, mental health, and cancer in general (Fife & Wright, 2000; 
Chapple, et al., 2004; Sarna, et al., 2005; Schmidt, Else-Quest, et al., 2006; Else-Quest, et 
al., 2009; and Unger, 2006). Although there have been several measures of stigma 
developed and tested with HIV/AIDS patients as well as cancer in general, only two other 
measures have specifically focused on lung cancer stigma (Fortenberry, et al., 2002; 
Brown, et al., 2003; Kang, et al., 2006; Buseh, et al., 2006; Berger, et al., 2001; Emlet, 
2005; Mak, Cheung, et. al. 2007). First, Hamann et al. (2014) used qualitative methods to 
identify stigma-related themes during semi-structured interviews with lung cancer 
patients. To date, however, there is not a published scale based on this work. Second, 
Cataldo’s 31-item lung cancer stigma scale (CLCSS) was adapted from the Berger et al. 
(2001) HIV measure and was found to be a reliable (coefficient alpha .96) and valid 
measure of stigma. The CLCSS has four subscales: stigma and shame; social isolation, 
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discrimination, and smoking ranging from 0.75 to 0.96 (Catlado, et al., 2011). The 
CLCSS is based on only one HIV stigma scale. In contrast, the LuCaSS includes items 
from three different HIV stigma scales (see Table 3.1). Each of the three HIV scales was 
representative of the multi-dimensional aspects of perceived stigma, The HIV Stigma 
Scale (Berger, et. al. 2001); Social Impact Scale (Fife & Wright, 2000), and HIV Stigma 
Scale (Emlet, 2005; Sowell et al., 1997), provided additional insights into the three 
LuCaSS constructs of stigma. For example, the Social Impact Scale not only includes 
social isolation, but also social rejection and internalized shame (Fife & Wright, 2000). 
This instrument was unique in that it was tested among HIV and cancer patients. 
Incorporating constructs from three different measures may have further captured the 
LuCaSS’ dimensionality of stigma while reducing the number of items necessary for 
patients to answer.  
Future studies are needed to establish the criterion related validity of the LuCaSS. 
For example, the LuCaSS could be compared with other measures of stigma in lung 
cancer patients (i.e., Cataldo et al., [2011] lung cancer stigma scale). In addition, because 
lung cancer stigma is closely related to smoking stigma, future studies could use the 
LuCaSS to examine stigma experiences among patients living in areas with and without 
smoke-free policies. 
The LuCaSS could be used in lung cancer diagnosis and treatment settings to 
identity potential patients who feel stigmatized to promote greater sensitivity from 
healthcare providers and family/support persons. Insensitive comments made by 
healthcare providers and loved ones may be a result of not knowing what to say, a 
reflection of their own fears about developing lung cancer, or lack of knowledge about 
the existence or impact of stigma. Comments may be made innocently without thinking 
about the impact on the patient feeling stigmatized. For example, healthcare providers 
and caregivers could be assessed for blame and anger toward lung cancer patients, 
particularly if the patient continues to smoke.. Sensitivity training with healthcare 
providers and caregivers may enhance the understanding of how negative and insensitive 
comments are linked to emotions and impact the ability to cope. Cancer treatment is 
challenging enough without adding hurt feelings or additional stress from insensitive 
comments. Healthcare providers and family members who recognize the potential for 
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stigma may have a greater ability to empathize with, advocate for, and provide 
unconditional support to the lung cancer patient.  
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Table 3.1. Description of measures used in the development of LuCaSS 
Author (Year); 
Instrument (s) 
Constructs 
measured 
# of Items; 
Response 
Scale 
LuCaSS 
items used 
from each 
scale 
Reliability 
coefficient 
alpha 
Model or 
theory 
Berger et.al. 
(2001) HIV 
Stigma Scale 
Personalized 
Stigma, 
Disclosure, 
Negative self 
image, Public 
Attitude 
40 –item 
4 pt Likert 
 
5 .96 Model of 
Perceived 
Stigma in 
People with 
HIV 
(Berger, 
2001) 
Fife & Wright 
(2000). Social 
Impact Scale 
Social Rejection 
& Financial 
insecurity, 
Internalized 
Shame & Social 
Isolation 
12-items 
 
12-items 
4-pt Likert 
7 .85-.90 
 
Modified 
Labeling 
Theory (Link 
et al. 1989) 
Emlet, (2005); 
Sowell, (1997) 
HIV Stigma 
Scale 
Distancing  
Blaming  
Discrimination  
13-item 
 
4-pt Likert 
 
3 .83 
 
 
Goffman 
(1963) 
Stigma 
Theory 
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Table 3.2. Sample Characteristics 
 
Characteristic n % 
Sex  
Female 50 48.1 
Male 54 51.9 
Ethnicity 
White 89 85.6 
Non-white 15 14.4 
Education  
High school graduate or less 62 59.6 
Some college or greater 42 40.4 
Marital Status 
Married/Cohabitating 59 56.7 
Widowed/ Divorced/ Separated 33 31.7 
Never married 12 11.5 
Employment  
Employed/Homemaker 18 17.3 
Retired 43 41.3 
Unemployed/disabled 43 41.3 
Annual income  
< $30,000 37 35.6 
$31,000 to $59,999 16 15.4 
>$60,000  22 21.2 
Preferred not to answer  29 27.9 
Insurance type 
Private 59 56.7 
Medicare/Medicaid 45 43.3 
Smoking Status  
Never 12 11.5 
Former 70 67.3 
Current 22 21.2 
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Table 3.3. Factor Loadings of the Lung Cancer Stigma Scale (LuCaSS) Items 
Statement Subscale Component 
 1 2 3 
I have been hurt by how people reacted to 
learning I have lung cancer 1 
Rejection 0.787 --- --- 
I feel others avoid me because of my lung 
cancer 2 
Rejection 0.773 --- --- 
People judge me for my type of cancer 1 Judgment 0.666 --- --- 
People’s attitude about lung cancer make 
me feel worse about myself 1 
Rejection 0.663 --- --- 
I worry that people will judge me when 
they learn I have lung cancer 1 
Judgment 0.641 0.538 --- 
I feel I have been treated with less respect 
than usual by others 2 
Judgment 0.618 --- --- 
I feel set apart from others who are well 2 Rejection 0.611 --- --- 
People who know I have lung cancer treat 
me with “kid gloves” 3 
Rejection 0.527 --- --- 
I feel I am at least partially to blame for my 
lung cancer 2 
Blame --- 0.812 --- 
I feel others think I am to blame for my 
lung cancer 2 
Blame --- 0.764 --- 
I feel guilty because I have lung cancer 1 Guilt --- 0.627 --- 
I do not think I can be open with others 
about my lung cancer 2 
Shame --- --- 0.774 
I feel I need to keep my lung cancer a 
secret 2 
Shame --- --- 0.691 
I feel/felt ashamed of my lung cancer 3 Shame --- --- 0.679 
I avoided getting treatment because 
someone might find out about my lung 
cancer 3 
Shame --- --- 0.571 
Sources: 1Berger, et. al. 2001; 2Fife & Wright, 2000; 3Emlet, 2005;Sowell et al., 1997. 
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Table 3.4. Correlations and Cronbach’s Alphas for the Lung Cancer Stigma Scale 
(LuCaSS) and Subscales 
Scale/Subscale Number 
of items 
Cronbach’s 
alpha 
Mean 
(SD) 
Pearson’s product moment 
correlations 
    Rejection/ 
Judgment 
Blame/ 
Guilt 
Shame 
LuCaSS Total 15 0.89 26.4 
(6.9) 
0.92 0.78 0.74 
Rejection/Judgment 8 0.87 14.0 
(4.0) 
1.00 0.57 0.54 
Blame/Guilt 3 0.74  6.2 (2.1)  1.00 0.44 
Shame 4 0.71  6.2 (1.9)   1.00 
Note. All correlations p<. 001 
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CHAPTER FOUR  
Lung Cancer Stigma, Social Support, and Psychosocial Distress  
Abstract 
Background: Lung cancer patients experience more psychosocial distress than those 
with any other type of cancer. Because lung cancer is closely associated with smoking, 
society often views the disease as self-inflicted contributing to the “blame the victim” 
mentality and the stigma and prejudice often experienced by lung cancer patients. 
Blaming patients who contract lung cancer may further influence our interactions with all 
lung cancer patients, regardless of their smoking status, denying them the social support 
routinely provided to those with other cancer diagnoses.  
Purpose: The purpose of this study was to investigate lung cancer stigma, social support, 
and psychosocial distress using an adapted Model of Stigma-Induced Identity Threat. The 
specific aims were to:  1) explore the relationships among social constraints, self-esteem, 
smoking and stigma; 2) determine the relationships of stigma with anxiety and 
depression, using smoking and socioeconomic status (SES) as covariates; and 3) 
determine if social support mediates the relationships between stigma and psychosocial 
distress (as measured by depression and anxiety). It was hypothesized that there would be 
a relationship among social constraints, self-esteem, smoking, and lung cancer stigma, 
and that social support would mediate the relationships between stigma and psychosocial 
distress.  
Methods: A cross-sectional study with a convenience sample of 104 patients between the 
ages of 18-85 diagnosed with lung cancer. Surveys were administered to lung cancer 
patients recruited from an NCI-designated lung cancer clinic using secure online data 
collection. Data collected included demographics (age, sex, education, employment, 
income, insurance), social constraints, self-esteem, smoking, lung cancer stigma, social 
support, depression and anxiety.  
Results: Social constraints, self-esteem, and smoking status each significantly 
contributed to the prediction of stigma controlling for SES. Social constraints contributed 
23%, self-esteem contributed 34%, and smoking status contributed 26% in the final 
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stigma model (adjusted R2=. 25, F=4.20, p=<. 0001). In the model without covariates, 
stigma was associated with depression (p=. 004) and anxiety (p=. 039). When controlling 
for covariates (SES and smoking), however, there was no longer a significant association 
between stigma and depression (p=. 229) or stigma and anxiety (p=. 128). Social support 
was a strong mediator for the relationship between stigma and depression but was not a 
mediator for anxiety. 
Discussion: There was a relationship among social constraints, self-esteem, smoking, and 
lung cancer stigma. Social support was a strong mediator for predicting the effects of 
stigma on depression but not anxiety. 
Conclusion: A lung cancer diagnosis can be associated with increased psychological 
distress and stigma. Lung cancer patients with greater social constraints and lower self-
esteem and who were smokers scored higher on stigma. It will be essential for healthcare 
providers to enhance social support for lung cancer patients to mitigate potential stigma 
and psychosocial distress. Integrating stigma tools (i.e. LuCaSS) in practice settings will 
assist with determining potential stigma related distress among lung cancer patients and 
future studies are required to further examine the role of social support in the experience 
of stigma and psychosocial distress in lung cancer patients. Such studies can contribute to 
minimizing stigma induced identity threat among lung cancer patients. 
Introduction 
A lung cancer diagnosis means poor survival rates (SEER, 2014), very few 
survivors or advocates (NCI, 2012), and limited research funding for awareness, 
prevention and treatment (Knapp-Oliver, et al., 2012, NCI, 2012). Because lung cancer is 
primarily caused by smoking, society often views the disease as self-inflicted. This view 
contributes to the “blame the victim” mentality (Alamar & Glantz, 2006; Gilpin, Lee, 
Pierce, 2004; Fichtenberg & Glantz, 2002) and the stigma and prejudice often 
experienced by lung cancer patients. Stigmatizing patients who contract lung cancer 
(Chappel et al., 2004; Stuber, et al., 2008) may deny them the social support routinely 
provided to those with other cancer diagnoses  (Raleigh, 2008; Cataldo et al., 2011).  
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Background 
Smoking Stigma.  
Smoke-free policy initiatives and antismoking campaigns are essential to reducing 
the harm from exposure to first and secondhand smoke. However, they may have 
unintended consequences resulting in the undesirable reputation and stereotyping of 
smoking and smokers (Bell, McCullough, et al., 2010; Bell, Salmon, et al., 2010;Stuber, 
et al., 2008; McCool, 2013).  As a result, smokers report feelings of shame, described as a 
dejected emotional state, placing their self-worth under attack and criticizing “the self” 
for failing to live up to the ideals of society (Stuber, et al., 2008; Ritchie, et al., 2010). 
Negative feelings about oneself can lead to poor self-esteem and self-concept, threatening 
a persons’ social identity and leading to psychosocial distress (Major and O’Brien, 2005). 
The growing negative perception of smoking may inadvertently result in stigma against 
lung cancer patients (Chapple et al., 2004; Bayer, 2008; Stuber, et al., 2008; Burris, 
2008). 
Stigma and Social Identity 
Stigma is defined as an attribute, behavior, or reputation which is socially 
discrediting in a particular way that may cause an individual to be perceived by others in 
an undesirable, rejected stereotype rather than in an accepted, normal one (Goffman, 
1963). Stigma occurs because of the human need to belong to a group and belonging to a 
group is necessary in order to establish a social identity (Tajfel and Turner, 2004; Turner, 
1979). Social identity is defined by social and physical characteristics that differentiate us 
such as race, ethnicity, religion, occupation, and behaviors (Turner, 1979). Social identity 
also affects our self-esteem and our connections or sense of membership with other 
people (Tajfel and Turner, 2004). We are motivated to protect our social identity from 
anything that causes harm or is devaluing in order to maintain our self-esteem and self-
concept (Steele and Aronson, 1995). Threats to our social identity can lead to 
psychosocial distress. 
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Psychosocial effects of lung cancer stigma.  
Lung cancer patients experience more stigma and psychosocial distress than those 
with any other type of cancer (Else-Quest, et al., 2009; Carlson et al., 2005; Chapple e al., 
2004). Psychosocial distress factors such as blame, depression, anxiety and poor quality 
of life have been positively correlated with lung cancer stigma (LoConte, Murdoch, 2008; 
Gonzalez and Jacobsen, 2010; Johnson, et al., 2014) and reflect feelings of 
discrimination, shame, guilt, and social isolation (Alamar & Glantz, 2006; Gilpin, Lee, 
Pierce, 2004; Fichtenberg & Glantz, 2002). Lung cancer stigma has also been linked to 
lack of empathy in interactions with lung cancer patients (Morse, et al., 2008) and delay 
in seeking medical help (Carter-Harris et al., 2014: Tod and Joanne, 2010). This occurs 
even though many patients experience symptoms prior to diagnosis (Corner, et al., 2005) 
but fear judgment from family and healthcare providers (Carter-Harris, et al., 2014; 
Stuber and Galea, 2009).  
Social Constraints and Psychosocial Distress.  
In addition to experiencing blame and low self-esteem (Else-Quest et al., 2009), 
patients with lung cancer also report significant social constraints (Badr & Carmack, 
2006; Bayer and Stuber, 2006). Social constraints are barriers that prevent an individual 
from expressing thoughts and feelings associated with a traumatic event due to negative 
reactions from others. Patients who experience a traumatic event, such as a cancer 
diagnosis, need to process the trauma to validate, appraise and find meaning necessary 
for successful psychological adjustments (Lepore & Helgeson, 1998; Cordova et al., 
2001). Minimizing social constraints by supporting the expression of thoughts and 
feelings may improve psychological adjustment and coping with psychosocial distress. 
Social Support.  
A main coping strategy necessary for ameliorating psychosocial distress is social 
support (Berger, Wagner, Baker, 2005; Brown, 2001; Crocker, Major, & Steele, Whereas 
unaddressed psychosocial distress can threaten ones’ self-esteem and social identity, 
social support can foster a person’s self-concept and social identity (Major and O’Brien, 
2005).  A cancer survivor’s ability to cope with the distress of the disease involves the 
“mutual influence” of their social network (significant others, family, friends) as a means 
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of cognitively and behaviorally addressing the stressors of the disease (Lepore & 
Revenson, 2007). Hence, understanding the role of social support in limiting the effects 
of psychosocial distress is essential in addressing lung cancer stigma. 
Conceptual Framework 
Based on the conceptual model of Stigma Induced Identity Threat (Major and 
O’Brien, 2005), having a “consensually devalued social identity (stigma)” increases the 
likelihood that an individual will experience potentially stressful (identity threatening) 
situations (Major and O’Brien, p. 398). Three factors influence identity threat and the 
significance of an individual’s appraisal of those factors: collective representations, 
situational cues, and personal characteristics (see Figure 4.1).  
Collective representations are based on previous experiences and awareness of 
cultural norms that enable stigmatized groups to incorporate shared understandings of the 
dominant view of their position in society (Crocker, 1999; Crocker et. al., 1998; Steel, 
1997). Situational cues and personal characteristics build on collective representations 
by reinforcing a lack of value, discrimination or negative stereotype. For example, anti-
smoking media messages may reinforce negative stereotypes of one’s group behavior 
(smoking) and the awareness that an evaluator (i.e., society, healthcare provider, patient 
support) is prejudice against one’s group (lung cancer patient). The Model of Stigma-
induced Identity Threat has been adapted to guide the study reported here to focus solely 
on the personal characteristics of stigma. Personal characteristics for this study included 
demographic factors such as age, sex, education and employment; social constraints, self-
esteem, and smoking (Major and O’Brien, 2005). 
The Model of Stigma-induced Identity Threat defines how having a stigmatized 
identity can lead to stress and stress-related health outcomes (Major and O’Brien, 2005). 
Threat is a situation that communicates the possibility of harm and having a stigmatized 
identity increases the individual’s exposure to identity –linked stressors. Stigma-induced 
identity threat results from discrimination or other identity-related threatening situations 
leading to psychological, social and physical outcomes such as stress, anxiety, and 
depression (Major and O’Brien, 2005; Steele and Aronson, 1995; Salvatore, and Shelton, 
2007). Identity threat occurs when an individual appraises demands (i.e., collective 
responses, situational cues, personal characteristics) imposed by a stigma-relevant 
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stressor as potentially harmful to their social identity and exceeds resources available to 
cope with those demands (Major and O’Brien, 2005). According to the model, volitional 
responses, such as seeking social support, influence our ability to cope by way of 
conscious cognitive processes to control emotion, perception, physical and behavioral 
responses to stressful situations or events.  
The purpose of this study was to determine the relationship among personal 
characteristics and lung cancer stigma, and the effects of stigma on psychosocial distress 
(i.e., anxiety and depression) guided by an adapted Model of Stigma-Induced Identity 
Threat. The specific aims were to:  1) explore the relationships among social constraints, 
self-esteem, smoking and stigma; 2) determine the relationships of stigma with anxiety 
and depression, controlling for smoking and socioeconomic status (SES); and 3) 
determine if social support mediates the relationships between stigma and psychosocial 
distress. It was hypothesized that there would be a relationship among social constraints, 
self-esteem, smoking, and lung cancer stigma. It was also hypothesized that social 
support would mediate the relationships between stigma and psychosocial distress (i.e., 
depression and anxiety).  
Methods 
Design and Sample 
This cross-sectional, descriptive study involved survey administration with a 
convenience sample of patients with lung cancer at the University of Kentucky 
Multidisciplinary Lung Cancer Clinic (UKMLCC) through the NCI-designated Markey 
Cancer Center.  The study population included patients between the ages of 18 to 85 
years of age and diagnosed with any stage non-small cell lung cancer (NSCLC) or small 
cell lung cancer (SCLC) within the past five years. Participants were required to be able 
to read and speak English and provide written documentation of consent. Approval was 
obtained from the medical Institutional Review Board. A total of 125 lung cancer patients 
were invited to participate; twenty-one (16.8%) declined to participate due to fatigue or 
poor health. The final sample comprised 104 patients. 
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Procedures 
Lung cancer patients visiting the UKMLCC clinic were pre-identified and 
screened according to the inclusion/exclusion criteria using Sunrise Clinical Manager, the 
electronic medical record. A total of 125 patients were approached to participate between 
July and August 2014. Of these participants, twenty-one (16.8%) declined due to fatigue 
or poor health. A total of 104 patients were consented to take part in the study 
(participation rate = 83.2%). The university’s medical institutional review board 
approved the study materials and procedures. With approval from clinic physicians, 
patients were pre-screened by diagnosis before approached by research staff.  The survey 
was administered using REDcap (Research Electronic Data Capture) electronic data 
capture  (Paul et al., 2009), a secure web-based application for building and managing 
online surveys and databases that is hosted by the university and facilitated by the 
researcher. Confidentiality was maintained by conducting all interviews in the clinic 
patient rooms where each question was read aloud to the patient by the research staff. 
Participants received a $10 gift card and a lung cancer awareness pin after completing the 
survey.  
Measures 
Lung Cancer Stigma  
The identity threat variable in the adapted Model of Stigma-induced Identity 
Threat (Major and O’Brien, 2005) was defined as lung cancer stigma and measured using 
the 15-item, self-report Lung Cancer Stigma Scale (LuCaSS), an investigator-developed 
survey that adapted items from three existing measures of HIV stigma (Fife & Wright, 
2000; Berger, et al., 2001; Emlet, 2005; Sowell et al., 1997). Items are rated on a 4-point 
Likert scale ranging from (1) ‘strongly disagree’ to (4) ‘strongly agree’. Items are 
summed to generate a total score ranging from 15 to 60 with higher total scores 
indicating greater perceived stigma. Subscales include judgment/rejection, blame/guilt, 
and shame. For example: “I avoided getting treatment because someone might find out 
about my lung cancer (judgment/rejection);” “I feel I need to keep my lung cancer a 
secret (shame);” “I have been hurt by how people reacted to learning I have lung cancer 
(blame/guilt).” The Cronbach’s alpha for the total LuCaSS in this sample was 0.89. 
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Psychosocial Distress 
Depression and anxiety were measured using the 15-item PROMIS Depression 
and Anxiety Scale (DeWalt, et al., 2007; Cella, et al., 2007). The PROMIS initiative, part 
of the National Institutes of Health, developed, validated, and standardized item banks to 
measure patient reported outcomes pertinent across common medical conditions (Fries et 
al., 2005; Kelly, et al., 2010). These instruments measure frequencies of symptoms 
reflecting negative affect (depression scale) and autonomic arousal and threat (anxiety 
scale) in the past month.  
The depression scale consists of eight items and the anxiety scale consists of 
seven items with strong psychometric properties. Items are rated on a 5-point Likert scale 
ranging from 1 (never) to 5 (always) and summed to generate a total score ranging from 
8-40 for depression and 7 to 35 for anxiety. Higher scores indicate greater depression and 
anxiety.  The Cronbach’s alpha for depression was 0.91 and the Cronbach’s alpha for 
anxiety was 0.93. A sample item for depression is:  “In the past month I felt worthless;” 
for anxiety “In the past month I felt worried.”  
Personal Characteristics 
According to the Model of Stigma-Induced Identity Threat (Major and O’Brien, 
2005), personal characteristics influence how situations are perceived and appraised. 
Personal characteristics included in the model adapted for the study reported here were 
social constraints, self-esteem, smoking, and demographics (see Figure 4.1). 
The Social Constraints Scale (SCS) (Lepore, 1997) measured the social 
conditions or environments that cause trauma by discouraging expression of emotions. 
Participants were asked to respond to the 15-item SCS to assess social constraints related 
to disclosure about cancer. Responses for each item were rated on a 4-point Likert scale 
ranging from (1) ‘never’ to (4) ‘often’. Total scores range from 15 to 60 with higher 
scores indicating greater social constraints. Sample items are: How often in the past 
month did your (family/friends) “change the subject when you tried to discuss your 
experience with cancer,” “avoid you,” and “give you the idea they didn’t want to hear 
about your experiences with cancer.” Cronbach’s alpha for the SCS for this sample was 
0.83. 
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Rosenberg Self Esteem is a widely used self-report instrument for evaluating 
individual self-esteem and is a measure of global self-worth for both positive and 
negative feelings about the self (Rosenberg, 1979). The construct was measured using the 
10-item uni-dimensional scale. Responses are rated on a 4-point Likert scale ranging 
from (1) ‘strongly agree’ to (4) ‘strongly disagree.’ A total score is calculated as the 
average of the 10-items with ranges from 10 to 40. Sample items are: “I take a positive 
attitude toward myself” and “I feel I do not have much to be proud of.” Being stigmatized 
may contribute to a lower self-esteem score and identity threat. Cronbach’s alpha was 
0.84 for this sample. 
Smoking items were adapted from the Global Adult Tobacco Survey 
Collaborative Group (GATS, 2011). This survey is considered standard for monitoring a 
variety of tobacco related questions to assess current, former and never tobacco use 
(GATS, 2011). A total of 8 questions measuring smoking history such as age of tobacco 
initiation, advice to quit, and quit attempts were included. Current smoking is defined as 
the percentage of respondents who had smoked tobacco in the past 30 days; former 
smoker is defined as the percentage of participants who had ever smoked but who were 
currently not smoking; never smokers are those who had never smoked and not currently 
smoking. For mediation analysis, smoking status was categorized into ‘current’ versus 
‘former/never’ smoker categories. 
Demographic variables. Sex (male/female), age of participants (in years), marital 
status (married/cohabitating vs. widowed/divorced/separated vs. never married), ethnicity 
[(white vs. non-white (African American, Asian, Hispanic)], educational level [(high 
school graduate or less, some college or greater (less than 1 year, college degree, 
Bachelors/Masters/Doctoral degree)], annual income level ($30,000 or less, $31,000-
59,999, $60,000 or greater, prefer not to answer), health insurance (private vs. 
Medicare/Medicaid) were assessed.  
Social Support 
Social support was selected as the volitional response variable, measured by the 
Duke—UNC Functional Social Support Questionnaire (DUKE SSQ), an 8-item self-
report scale designed to measure satisfaction with available social support (Broadhead et 
al., 1988). Items were rated on a 5-point Likert scale ranging from 1 (much less than I 
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would like) to 5 (as much as I would like). Items are summed to create a total score 
ranging from 8 to 40 with higher total scores indicating greater social support. Sample 
items include: ‘People care what happens to me…’ and ‘chances to talk to someone I 
trust about my personal and family problems,’ with responses ranging from ’as much as I 
would like’ to ‘much less than I would like.’ Cronbach’s alpha for the Duke SSQ in this 
sample was 0.83. 
Data Analysis 
The study variables were summarized using frequencies (for categorical) or 
means with standard deviations (for continuous variables).  Personal characteristics 
including, social constraints, self-esteem, smoking, demographics and lung cancer stigma 
(i.e., identity threat), and social support (i.e., volitional responses); and depression and 
anxiety were tested for bivariate associations using chi-square analyses for categorical 
variables and t-tests for continuous variables.  Relationships between the personal 
characteristics and outcome variables were determined using the two-sample t-test, 
analysis of variance (ANOVA), and the Kruskal-Wallis test. Pearson’s correlations were 
used to assess associations between continuous demographic and personal variables and 
the main outcome variables. Post hoc analysis was performed when the ANOVA 
indicated a significant group effect overall.  
To test whether social support mediated the relationship between stigma and 
depression/anxiety (see Figure 4.2), multiple regression analysis was used following the 
four-step method described by Baron and Kenny (1986). For this study, the four steps to 
be satisfied before mediation could take place included ensuring that: 1) the predictor 
variable (stigma) was a significant predictor of the mediator variable (social support); 2) 
the predictor variable (stigma) was a significant predictor of the outcome variable 
(depression); 3) the mediator (social support) was a significant predictor of the outcome 
(depression); and 4) when both the mediator (social support) and the predictor (stigma) 
were included in the same regression as potential predictors of the outcome (depression), 
the latter was no longer significant. The Sobel test was performed to assess the statistical 
significance of the indirect effect of the mediator in each of the mediation models (Sobel, 
1982).  
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The multiple regression standardized beta weights were used to summarize the 
direct and indirect effects of the predictor or mediator on the outcome as the direct effect 
(i.e., the regressions with just one independent variable) and the indirect effect of stigma 
on the outcome when the mediator was included in the regression. Each regression model 
contained the following demographic and personal characteristics as control variables: 
age, sex, smoking status (current vs. former/never), and employment status 
(retired/disabled vs. other). These control variables were chosen because they are the 
known demographic and disease-specific indicators that may be most closely aligned 
with the outcomes. All analyses were performed using the SPSS Statistics 22.0. An alpha 
level of .05 was used throughout the analysis (SPSS, 2009). 
Results 
Demographic Characteristics 
Table 4.1 summarizes the characteristics of the sample. The sex of participants 
was approximately equally distributed (48% women). Participants were primarily white 
(86%), former smokers (67%), and married (57%), with a mean age of 61.9 (SD = 9.2) 
years. Sixty percent had a high school degree or less education. Most participants were 
either retired (41%) or unemployed/disabled (41%) and more than half had private 
insurance (57%). More than half of participants made less than $60,000/year (51%); 
nearly one in three preferred not to disclose annual income (28%).  
Scale scores 
The average score on the LuCaSS scale was 26.4, (SD= 6.7). The depression 
subscale score was 16.3 (SD=6.8); anxiety subscale score was 17.3 (SD=7.0). The social 
constraints scale was 22.2 (SD= 6.6); self-esteem scale score was 22.5 (SD=4.9), and the 
social support scale was 35.4 (SD=5.7). 
Associations of social constraints, self-esteem, and smoking with stigma  
Aim 1 was to examine the associations of social constraints, self-esteem and 
smoking with stigma (see Table 4.2). Controlling for SES variables, social constraints, 
self-esteem, and smoking status each significantly contributed to stigma. Social 
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constraints contributed 23%, self-esteem contributed 34%, and smoking status 
contributed 26% to stigma in the final model. 
Association of stigma with anxiety and depression controlling for SES and smoking  
For Aim 2, the relationships of stigma with anxiety and depression were 
examined (see Table 4.3). In the model without covariates, stigma was associated with 
depression (p=. 004) and anxiety (p=. 039). When controlling for SES and smoking, there 
was no longer a significant association between stigma and depression (p=. 229) or 
stigma and anxiety (p=. 128).  
Test of social support as a mediator of the relationships of stigma with depression 
and anxiety  
For Aim 3, a mediation analysis was conducted to test whether social support 
mediated the relationship of stigma with depression and anxiety (see Table 4.5). Social 
support was a strong mediator of the relationship between stigma and depression (Figure 
4.2). However, social support was not a mediator of the relationship between stigma and 
anxiety, because stigma did not significantly predict anxiety.  
Discussion 
The first hypothesis was that there would be a relationship among social 
constraints, self-esteem, smoking, and lung cancer stigma. Indeed, lung cancer patients 
who reported greater social constraints, lower self-esteem, and who were current smokers 
scored higher on the stigma measure. Consistent with the literature, lung cancer patients 
experiencing stigma may also encounter greater social constraints and lower self-esteem 
(Badr, and Taylor, 2006; Else-Quest, et al., 2010; Cataldo, et al., 2011). Further, smokers 
experience more stigma than non-smokers (Chapple, et al., 2004; Gulyn & Youssef; 
2010; Cataldo, et al., 2011).  
Individuals who experience social constraints may avoid talking about cancer in 
an attempt to buffer against upsetting “intrusions” such as being blamed for their 
smoking behavior. The findings indicated that social constraints were significantly 
associated with stigma even after controlling for SES, social constraints, self-esteem, and 
smoking. Experiencing social constraints may be associated with stigma by directly 
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exposing the stigmatized to environments that limit access to supportive relationships and 
resources (Link & Phelan, 2001). However, supportive social networks can provide a 
context for cognitive processing of traumatic events utilizing verbal disclosure of 
thoughts and feelings, which can improve mental health (Lepore and Helgeson, 1998). 
Stigma contributes to low self-esteem, can threaten a person’s identity and varies 
as a function of personal characteristics (Crocker, 1999). In one study for example, 
pessimistic women who were exposed to persistent sexism experienced more threat 
appraisals and lower self-esteem than optimistic women (Kaiser, et al., 2004). 
Longitudinal and cross-sectional studies of individuals experiencing stigmatized 
identities have shown that stigma precedes reduced self-esteem in people with mental 
illness (Verhaeghe, et al., 2008), individuals with HIV (Fife and Wright, 2000), and in 
those with lung cancer (Fife and Wright, 2000; Else-Quest, et al., 2010; Cataldo, et al., 
2011).   
Lung cancer patients who smoke experience more stigma than non-smokers 
(Stuber, et al., 2008). The level of responsibility that a person assigns to their illness (i.e., 
smoking as a cause of lung cancer) determines the degree of perceived stigma (Falk, 
2001). Controllable factors such as smoking, elicit greater negative reaction than from 
uncontrollable factors (Falk, 2001). Smokers are viewed more negatively and experience 
more self-blame than non-smokers (LoConte, Else-Quest, et al., 2008; Gulyn, & Youssef, 
2010) due, in part, to the unintended consequences of smoke-free policies and anti-
smoking campaigns (Stuber, et al., 2008; Fichtenberg & Glantz, 2002).  
For the second hypothesis, social support mediated the relationship of stigma with 
depression. Social support was a strong mediator for predicting the effects of stigma on 
depression; when included in the model, social support changed the relationship between 
stigma and depression, suggesting that strong social support may decrease the negative 
effect of stigma on depression. Therefore, it is possible that in understanding depression 
among lung cancer patients, social support may lessen the impact of depression as a 
result of their feelings or experiences of being stigmatized. These findings are 
preliminary and need to be replicated to better understand the nature of the relationships 
between stigma, social support and depression.  
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Social support was not a mediator for predicting the effects of stigma on anxiety. 
There was not an observed relationship between the independent variable (stigma) and 
the dependent variable (anxiety). In the mediation model, the effects of stigma on anxiety 
were not significant, and social support was not a mediator of stigma and anxiety. This 
finding could be related to the time parameters on the anxiety survey instrument “in the 
past month” that may have influenced responses. Also, the data are cross-sectional and 
finding a convincing association may be more likely in a longitudinal design. It is 
possible that anxiety (feeling fearful, anxious, worried, nervous, uneasy, tense) could 
precede or contribute to stigma or perhaps social support is not the best mediator or 
volitional response. There may be other positive mediators, such as meditation or specific 
complimentary therapies that may impact the effects of stigma on anxiety. Future studies 
are needed to further examine the association between stigma and anxiety using robust 
data sets and longitudinal design.  
Limitations 
There are several limitations to this study. First, the non-probability sample did 
not fully represent the general lung cancer population. The sample was homogenous with 
respect to race and ethnicity, which limits generalizability to the broader lung cancer 
population. The sample size was small (n =104), although adequately powered based on 
preliminary power analysis calculations (Cohen, 1988). The age of the sample was 
slightly younger than the national average (62 years vs. 72 years) (ACS, 2012). There 
may have been some bias in that almost all interview responses were given aloud with a 
caregiver/family/friend in the room and this may have influenced the truthfulness in 
answering questions related to anxiety, social constraints and social support. Finally, lung 
cancer awareness has been growing steadily for the last eight years (Norris, 2015), which 
may have affected how the population perceives stigma or other variables such as patient 
support organizations and advocacy events affecting some of the main outcomes.   
Future Research 
Future psychometric testing of the LuCaSS is needed with a larger more diverse 
population. While the LuCaSS assesses perceived stigma of an individual diagnosed with 
lung cancer, studies are needed to examine differences in perceived stigma between 
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patient and caregiver. Further, research is needed to evaluate the feasibility and usability 
of implementing the LuCaSS as part of the clinical assessment when patients are initially 
diagnosed with lung cancer. If stigma can be identified early in the lung cancer diagnosis, 
interventions including social support can be developed and tested to minimize identity 
threat and psychosocial distress.  
Other research implications may include exploring if lung cancer patients from 
counties/cities with smoke-free policy experience more stigma than those without a 
smoke-free policy. Anti-smoking and dangers of secondhand smoke messages may be 
more prevalent in smoke-free areas contributing to the societal view of smokers and lung 
cancer stigma. There may be opportunities to explore if interventions aimed at providing 
social support through advocacy can impact stigma outcomes.  
Experiencing stigma can lead to psychosocial distress. Recognizing distress is one 
of the quality measures recommended by the Commission on Cancer (CoC), a program of 
the American College of Surgeons (ACoS), that recognizes cancer care programs for 
their commitment to providing comprehensive, high quality, and multidisciplinary patient 
centered care. The CoC is dedicated to improving survival and quality of life for cancer 
patients through standard setting and the monitoring of comprehensive quality care. 
Psychosocial Distress Screening (Standard 3.2) is a 2012 Standard and must be phased-in 
for 2015 (Commission on Cancer, 2012).  All cancer programs will need to demonstrate 
that they screen patients diagnosed with cancer for distress. Through the CoC standards, 
the LuCaSS may help identify stigma that leads to psychosocial distress and can 
negatively impact the wellbeing of the lung cancer patient.  
Conclusion 
A lung cancer diagnosis can be associated with stigma and increased psychosocial 
distress (Else-Quest, et al., 2006; Chapple, et al., 2004; Cataldo, et al., 2011). The 
findings of the study reported here are consistent with the Model of Stigma Induced 
Identity Threat (Major and O’Brien, 2005) which states that having a stigmatized identity 
can be affected by social constrains, lower self-esteem, smoking and can lead to stress 
and stress-related health outcomes such as depression and anxiety (Major and O’Brien, 
2005). To date, no other studies have applied the Model of Stigma Induced Identity 
Threat to lung cancer stigma research or tested whether social support mediated the 
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relationship between stigma and depression/anxiety. These findings specifically 
emphasize the need for healthcare providers to enhance social support for lung cancer 
patients in order to mitigate potential stigma and psychosocial distress. In addition, it is 
important to find a way to integrate stigma tools (i.e. LuCaSS) in practice settings when 
encountering lung cancer patients to determine potential stigma related distress. Finally, 
future studies are required to further examine the role of social support in the experience 
of stigma and psychosocial distress in lung cancer patients. Such studies can contribute to 
minimizing stigma induced identity threat among lung cancer patients. 
 
 
Copyright © Lisa Maggio 2015 
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Table 4.1. Sample Characteristics (N=104) 
Characteristic n % 
Sex    
Female 50 48.1 
Male 54 51.9 
Ethnicity 
  
White 89 85.6 
Non-white 15 14.4 
Education 
  
High school or less 62 59.6 
Some college or greater 42 40.4 
Marital status 
  
Married/Cohabitating 59 56.7 
Widowed/Divorced/Separated 33 31.7 
Never married 12 11.5 
Employment 
  
Employed/Homemaker 18 17.3 
Retired 43 41.3 
Unemployed/disabled 43 41.3 
Annual income 
  
Less than $30,000 37 35.6 
$31,000 to $59,000 16 15.4 
$60,000 or more 22 21.2 
Prefer not to answer 29 27.9 
Insurance type 
  
Private 59 56.7 
Medicare/Medicaid 45 43.3 
Smoking Status 
  
Never 12 11.5 
Former 70 67.3 
Current 22 21.2 
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Table 4.2. Association of Stigma with Each of Social Constraints, Self-Esteem, and 
Smoking, Controlling for SES 
 
Note: Final model controlling for sex, age, marital status, education, employment status, race and 
type of insurance.  
Adjusted R2 =. 25, F=4.2, df=10, p=<. 0001 
 
Variables Estimated Beta t (p-value) 
Social Constraints  .23 2.3 (.021) 
Self-esteem  -.34 -3.3  (.002) 
Smoking status (former/current vs. 
never smoker 
.26 2.8  (.006) 
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Table 4.3. Association of Stigma with Each of Depression and Anxiety, Unadjusted 
for Covariates and Adjusted for SES and Smoking  
Note: Model for depression and anxiety were adjusted for SES and smoking status. 
Adjusted model for depression, adjusted R2 =. 27, F=5.02, p<. 0001); Adjusted model for anxiety, 
adjusted R2 =. 05, F=1.53, p=. 149. 
 
Variable Beta t (p-value) 
LuCaSS Scale Score (unadjusted)  
Depression .28  2.94 (.004)  
Anxiety .20 2.09 (.039) 
LuCaSS Scale Score (adjusted for covariates) 
Depression .12 1.21 (.229)  
Anxiety .18 1.53  (.128) 
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Table 4.4. Means, Standard Deviations and Correlations Among Predictor, 
Mediator and Dependent Variables (N = 104) 
Variable Variable type Correlation (p-value) 
Stigma Social support Depression 
Stigma Predictor    
Social Support Mediator -.32 (.001)   
Depression Outcome .28 (.004) -.37 (<. 001)  
Anxiety Outcome .20 (.039) -.26 (.008) .73 (<.001) 
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Table 4.5. Test of Mediation for the Relationships of Stigma and Social Support as 
They Predict Depression and Anxiety (N = 104)* 
1. Social Support mediates the effect of Stigma on Depression. 
Predictor Potential 
mediator 
Outcome Std b for 
predictor 
p-value Sobel test p-value 
Stigma  Social support -0.31 .003  
Stigma  Depression 0.20 .029  
Support  Depression -0.26 .004  
Stigma Support Depression 0.11 .23 .020 
      
2. Social Support does not mediate the effect of Stigma on Anxiety. 
Predictor Potential 
mediator 
Outcome Std b for 
predictor 
p-value Sobel test p-value 
Stigma  Social support -0.31 .003  
Stigma  Anxiety 0.18 .086  
Support  Anxiety -0.23 .025  
Stigma Support Anxiety 0.13 .25 .070 
*Note – Covariates included in each model were: age, sex, employment status and current 
smoking status. 
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Figure 4.1 An Identity-Threat Model of Stigma in Lung Cancer 
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Figure 4.2.  Direct and Indirect Effects of Stigma on Depression and Anxiety. 
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CHAPTER FIVE 
Conclusions 
Three papers were presented in this dissertation: 1) “Stigma, Smoking and Lung 
Cancer: A Systematic Review of the Literature;” 2) “Lung Cancer Stigma Scale 
(LuCaSS): Measuring Perceived Stigma in People with Lung Cancer;” and 3) “Lung 
Cancer Stigma, Social Support, and Psychosocial Distress.” 
The first paper was a systematic review and the primary aims were to: a) explore 
the concepts of health-related stigma; b) describe the current status of lung cancer 
research funding and advocacy related to lung cancer stigma; c) explore the relationship 
between smoking stigma and lung cancer; and d) provide an overview of the Model of 
Stigma-Induced Identity Threat and the psychosocial effects of being stigmatized.  
Stigma is a social process resulting in discrediting or devaluation of a person or 
group and exists as a means of social control and regulating behavior (Goffman, 1963). 
Stigma is most likely to exist among people with diseases linked to controllable causes 
such as smoking (Falk, 2001), prompting less empathy and more blame (Chapple, et al., 
2004; Gulyn and Youssef, 2010) compared to other diseases with a less known cause. 
Smoking represents the primary cause of lung cancer and is related to growing negative 
public perceptions that unintentionally result in stigma against lung cancer patients 
(Fichtenberg and Glantz, 2002; Stuber, et al., 2008). As a result, lung cancer patients are 
often viewed as responsible for or deserving of their disease regardless of their smoking 
status and they may experience higher levels of cancer-related stigma than patients with 
other cancers (Stuber, et al., 2008)  
The stigma experienced by many lung cancer patients negatively impacts 
psychological adjustments and interpersonal communication. The Model of Stigma-
Induced Identity Threat explains how stigma “threatens a person’s identity,” or their self-
concept and is associated with greater distress, poorer psychological adjustment (Major 
and O’Brien, 2005), and limited use of support services (Morse, et al., 2008; Carter-
Harris et al., 2014). Lung cancer stigma as “identity threat” may have influenced the lag 
in appropriate research funding and advocacy related to lung cancer, limiting advances in 
better prevention, treatment, and survival (Knapp-Oliver and Moyer 2012). The Model of 
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Stigma-Induced Identity Threat was adapted to guide research described in the second 
and third papers.  
The second paper was a psychometric analysis of the Lung Cancer Stigma Scale 
(LuCaSS), developed by the investigator to assess perceived stigma in lung cancer 
patients and address the void in brief measures currently available. The purpose of this 
study was to describe the development of an investigator-developed instrument, “Lung 
Cancer Stigma Scale” (LuCaSS) and evaluate its psychometric properties by: 1) 
describing the internal consistency of the LuCaSS; and 2) assessing the construct validity 
of the instrument through principle components analysis (PCA).  
There is convincing scientific evidence that lung cancer patients experience 
stigma and are at high risk for psychosocial distress (Chapple, et al., 2004; Cataldo, et al., 
2011; Else-Quest, et al., 2009). The development of this instrument was adapted from 
those known to measure HIV stigma (Berger, et. al. 2001; Fife & Wright, 2000; Emlet, 
2005; and Sowell et al., 1997). The LuCaSS was found to be a reliable and valid 
instrument measuring lung cancer stigma. Three subscales measuring internalized stigma 
were identified: social rejection/judgment, blame/guilt, and shame. Testing instruments 
that assess stigma assist in understanding the salient constructs associated with stigma 
and are necessary to test interventions that may minimize stigma experienced by lung 
cancer patients.  
The third paper investigated lung cancer stigma, social support, and psychosocial 
distress using the adapted Model of Stigma-Induced Identity Threat. Because lung cancer 
is closely associated with smoking, society often blames lung cancer patients (Gulyn and 
Youssef, 2010; Ritchie, et al., 2010; Chapple, et al., 2004). This may affect interactions 
with all lung cancer patients, regardless of their smoking status, creating psychosocial 
distress (Chapple, 2004; Gonzalex and Jacobsen, 2010; Cataldo, et al., 2011; Johnson, et 
al., 2014) and denying them the social support routinely provided to those with other 
cancer diagnoses (Badr, and Taylor, 2006; Else-Quest, et al., 2009; LoConte, et al., 
2008).  
The purpose of this study was to determine the relationship among personal 
characteristics and lung cancer stigma, and the effects of stigma on psychosocial distress 
(i.e., anxiety and depression) guided by an adapted Model of Stigma-Induced Identity 
 72 
Threat. The specific aims were to:  1) explore the relationships among social constraints, 
self-esteem, smoking and stigma; 2) determine the relationships of stigma with anxiety 
and depression, controlling for smoking and socioeconomic status (SES); and 3) 
determine if social support mediates the relationships between stigma and psychosocial 
distress. It was hypothesized that there would be a relationship among social constraints, 
self-esteem, smoking, and lung cancer stigma. It was also hypothesized that social 
support would mediate the relationships between stigma and psychosocial distress (i.e., 
depression and anxiety).  
A convenience sample of lung cancer patients (N = 104) were recruited from the 
University of Kentucky Multidisciplinary Lung Cancer Clinic (UKMLCC) through the 
NCI-designated Markey Cancer Center. Participants were surveyed in a cross-sectional 
study to explore the relationship among social constraints, self-esteem, smoking, and lung 
cancer stigma. Social support was also investigated as a mediator in the relationships 
between stigma and psychosocial distress (depression and anxiety). Lung cancer patients 
who reported greater social constraints, lower self-esteem, and who were current smokers 
scored higher on the stigma measure. Social support may be a meaningful coping strategy 
and was found to be a strong mediator for predicting the effects of stigma on depression 
but not anxiety. The findings are consistent with the Model of Stigma Induced Identity 
Threat, having a stigmatized identity can lead to stress and stress-related health outcomes 
such as depression.  
Future Research and Practice Implications 
Future studies are needed to advance understanding of lung cancer stigma and the 
effects on patients and their caregivers, as well as to develop and test interventions to 
minimize stigma in this high-risk population. Although the LuCaSS developed and tested 
in this dissertation was found to be a reliable and valid tool, future research is warranted 
to compare the LuCaSS with other newly designed measures of lung cancer stigma (i.e. 
Cataldo et al., 2011) to establish criterion related validity. Additional psychometric 
testing is also needed to test the LuCaSS with a larger more diverse population. The 
LuCaSS assesses an individual’s perceived stigma when they are diagnosed with lung 
cancer. Differences in perceived stigma between healthcare providers, and caregivers 
could also be examined. The LuCaSS could also be evaluated for feasibility and usability 
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as part of the clinical assessment when patients are initially diagnosed with lung cancer. 
Implementing the LuCaSS to identify perceived stigma could, in part, satisfy the 
Commission on Cancer (CoC) psychosocial distress screening standard for quality 
measures.  
Future research is also needed to explore if lung cancer patients from 
counties/cities with smoke-free policy experience more stigma than those without a 
smoke-free policy. If this is determined, clinical settings and public health organizations 
could partner to develop and test interventions to minimize stigma in these communities. 
The findings from this study specifically emphasize the need for healthcare providers to 
enhance social support for lung cancer patients to mitigate potential stigma and 
psychosocial distress. Further, the impact of advocacy events (e.g., lung cancer 
walks/runs) and/or other interventions designed to provide social support could be tested 
to examine whether participation in these events might diminish the effects of stigma on 
depression in lung cancer patients. In addition, future studies are required to further 
examine the role of social support in the experience of stigma and psychosocial distress 
in lung cancer patients. Such studies can contribute to minimizing stigma induced 
identity threat among lung cancer patients. 
Finally, stigma in lung cancer occurs, in part, as an unintended consequence of 
smoke-free policies and antismoking campaigns. Some may question if it is ethical to 
stigmatize smokers in order to change behavior and social norms associated with 
smoking? Although the ethical considerations have been argued (Bayer, 2008; Burris, 
2008), the more appropriate question is what can be done to minimize stigma? If the goal 
is to decrease the effects of smoking related stigma on lung cancer patients, strategies 
learned from other stigmatized health conditions could be developed and tested to reduce 
lung cancer stigma (Berger et al., 2005). For example, to lessen the stigma associated 
with lung cancer stigma, it is important to cast the disease as treatable. When there is fear 
associated with the disease due to limited treatment and survival, there is greater stigma 
(Goffman, 1963; Falk, 2001).  
Some advances in lung cancer prevention, early detection and treatment are being 
made. Early detection and prevention continue to be addressed through tobacco treatment 
(Fiore, 2008), smoke- and tobacco-free policy (Callinan, et al. 2014), and early detection 
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through low dose CT screening (Wood, et al., 2012). Early detection and screening for 
lung cancer may provide the “hope” necessary to identify “at risk” patients and lead to 
improved survival rates for lung cancer patients. Other advances in treating lung cancer 
that are making a small impact on survival include the identification of actionable 
mutations and discoveries of newer targeted therapies (Johnson and Schiller, 2014).  
Although there have been some advances in prevention and treatment, the 
challenges for lung cancer patients are still enormous. Lung cancer is severely 
underfunded in both the public and private sectors. The two main factors contributing to 
underfunding lung cancer research are stigma and the dismal 5-year survival rate (Knapp-
Oliver and Moyer, 2012), which hasn’t changed in 40 years (13% in the 1970’s versus 
17% in 2013) (SEER, 2013). The poor survival rate affects the number of survivors 
available to advocate for awareness and adequate funding for better treatments. Unless 
these factors are addressed, efforts to improve the lives of lung cancer patients and 
impact survival may not be attainable.  
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